3170 genotypes with 6407 annotations displayed
of selected term and subterms
|
Searched Term: abnormal glucose homeostasis
|
2210408I21Riktm1b(EUCOMM)Wtsi/2210408I21Riktm1b(EUCOMM)Wtsi
(C57BL/6N-2210408I21Riktm1b(EUCOMM)Wtsi/Tcp)
|
impaired glucose tolerance
|
J:211773
|
4833411C07Rikem1Cecad/4833411C07Rikem1Cecad
(C57BL/6N-4833411C07Rikem1Cecad)
|
impaired glucose tolerance
|
J:285483
|
increased circulating glucose level
|
J:285483
|
insulin resistance
|
J:285483
|
4930505A04Riktm1b(KOMP)Wtsi/4930505A04Riktm1b(KOMP)Wtsi
(C57BL/6N-4930505A04Riktm1b(KOMP)Wtsi/Bay)
|
decreased circulating glucose level
|
J:211773
|
4930563E22Riktm1.1(KOMP)Vlcg/4930563E22Riktm1.1(KOMP)Vlcg
(B6N(Cg)-4930563E22Riktm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
4932438A13Riktm1b(EUCOMM)Hmgu/4932438A13Rik+
(C57BL/6N-4932438A13Riktm1b(EUCOMM)Hmgu/Ieg)
|
impaired glucose tolerance
|
J:211773
|
increased circulating glucose level
|
J:211773
|
4933402J07Rikem1(IMPC)J/4933402J07Rikem1(IMPC)J
(C57BL/6NJ-4933402J07Rikem1(IMPC)J/Mmjax)
|
improved glucose tolerance
|
J:211773
|
a/a Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6 * KK)
|
decreased circulating glucose level
|
J:168271
|
improved glucose tolerance
|
J:168271
|
a/Ay Guq1KK/Guq1KK
(involves: C57BL/6J * KK-Ay)
|
increased urine glucose level
|
J:131439
|
a/Ay Guq2C57BL/6J/Guq2C57BL/6J
(involves: C57BL/6J * KK-Ay)
|
increased urine glucose level
|
J:131439
|
A1cftm1c(EUCOMM)Hmgu/A1cftm1c(EUCOMM)Hmgu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6N * DBA)
|
decreased circulating glucose level
|
J:281365
|
decreased circulating insulin level
|
J:281365
|
decreased fasting circulating glucose level
|
J:281365
|
impaired gluconeogenesis
|
J:281365
|
improved glucose tolerance
|
J:281365
|
increased insulin sensitivity
|
J:281365
|
increased liver glycogen level
|
J:281365
|
Ay/a
(involves: KK)
|
hyperglycemia
|
J:26460
|
impaired glucose tolerance
|
J:26460
|
increased circulating insulin level
|
J:26460
|
increased urine glucose level
|
J:26460
|
insulin resistance
|
J:26460
|
Ay/a Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)
|
hyperglycemia
|
J:177084
|
increased circulating insulin level
|
J:177084
|
insulin resistance
|
J:177084
|
Ay/a Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6 * KK)
|
decreased circulating glucose level
|
J:168271
|
improved glucose tolerance
|
J:168271
|
Aak1tm1b(EUCOMM)Hmgu/Aak1tm1b(EUCOMM)Hmgu
(C57BL/6N-Aak1tm1b(EUCOMM)Hmgu/Orl)
|
impaired glucose tolerance
|
J:211773
|
Aasdhppttm1.1(KOMP)Vlcg/Aasdhppt+
(B6N(Cg)-Aasdhppttm1.1(KOMP)Vlcg/J)
|
improved glucose tolerance
|
J:211773
|
Abca7tm2b(EUCOMM)Hmgu/Abca7tm2b(EUCOMM)Hmgu
(B6N(Cg)-Abca7tm2b(EUCOMM)Hmgu/J)
|
decreased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Abcb4em1(IMPC)H/Abcb4em1(IMPC)H
(C57BL/6NTac-Abcb4em1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
Abcb11tm1Wng/Abcb11tm1Wng
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased liver glycogen level
|
J:67548
|
Abcc5em1(IMPC)H/Abcc5em1(IMPC)H
(C57BL/6N-Abcc5em1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
impaired glucose tolerance
|
J:211773
|
Abcc8em1(IMPC)J/Abcc8em1(IMPC)J
(C57BL/6NJ-Abcc8em1(IMPC)J/Mmjax)
|
impaired glucose tolerance
|
J:211773
|
Abcc8tm1.1Fmas/Abcc8tm1.1Fmas
(B6.129S2(Cg)-Abcc8tm1.1Fmas)
|
decreased circulating glucose level
|
J:208932
|
decreased insulin secretion
|
J:208932
|
impaired glucose tolerance
|
J:208932
|
increased circulating glucose level
|
J:208932
|
increased insulin secretion
|
J:208932
|
Abcc8tm1.1Mgn/Abcc8tm1.1Mgn
(involves: 129X1/SvJ * C57BL/6)
|
decreased insulin secretion
|
J:79352
|
hypoglycemia
|
J:79352
|
impaired glucose tolerance
|
J:79352
|
Abcc8tm1Jbry/Abcc8tm1Jbry
(involves: 129X1/SvJ * C57BL/6)
|
hypoglycemia
|
J:61356
|
impaired glucose tolerance
|
J:61356
|
Abcc8tm1Jbry/Abcc8tm1Jbry
(involves: 129X1/SvJ)
|
abnormal insulin secretion
|
J:179577
|
decreased circulating glucose level
|
J:179577
|
decreased insulin secretion
|
J:179577
|
increased circulating glucose level
|
J:179577
|
Abcc8tm1Jbry/Abcc8tm1Jbry Sstr5tm1Fcb/Sstr5tm1Fcb
(involves: 129X1/SvJ)
|
abnormal insulin secretion
|
J:179577
|
decreased circulating glucose level
|
J:179577
|
decreased insulin secretion
|
J:179577
|
increased circulating glucose level
|
J:179577
|
Abcc9tm1Cfb/Abcc9tm1Cfb
(involves: CD-1)
|
hypoglycemia
|
J:71840
|
improved glucose tolerance
|
J:71840
|
increased insulin sensitivity
|
J:71840
|
Abcd3em1(IMPC)J/Abcd3em1(IMPC)J
(C57BL/6NJ-Abcd3em1(IMPC)J/J)
|
improved glucose tolerance
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Abcg1tm1Asch/Abcg1tm1Asch
(involves: 129X1/SvJ * C57BL/6)
|
hypoglycemia
|
J:122438
|
Abcg2em1Omw/Abcg2em1Omw
(C57BL/6J-Abcg2em1Omw)
|
increased circulating glucose level
|
J:292268
|
increased circulating insulin level
|
J:292268
|
Abcg2tm1.1Ssf/Abcg2tm1.1Ssf
(involves: 129 * C57BL/6 * FVB)
|
abnormal glucose homeostasis
|
J:201884
|
decreased liver glycogen level
|
J:201884
|
impaired glucose tolerance
|
J:201884
|
Abcg8tm1b(KOMP)Wtsi/Abcg8tm1b(KOMP)Wtsi
(C57BL/6N-Abcg8tm1b(KOMP)Wtsi/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Abhd5tm1.1Rze/Abhd5tm1.1Rze
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating glucose level
|
J:160725
|
Abhd5tm1Rze/Abhd5tm1Rze Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
abnormal glucose homeostasis
|
J:197835
|
decreased circulating glucose level
|
J:197835
|
decreased circulating insulin level
|
J:197835
|
improved glucose tolerance
|
J:197835
|
Abhd6tm1a(EUCOMM)Hmgu/Abhd6+
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu)
|
increased insulin secretion
|
J:215257
|
Abhd6tm1a(EUCOMM)Hmgu/Abhd6tm1a(EUCOMM)Hmgu
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu)
|
decreased circulating insulin level
|
J:234876
|
decreased insulin secretion
|
J:234876
|
improved glucose tolerance
|
J:234876
|
increased circulating insulin level
|
J:215257
|
increased insulin secretion
|
J:215257,
J:234876
|
increased insulin sensitivity
|
J:234876
|
Abhd6tm1c(EUCOMM)Hmgu/Abhd6tm1c(EUCOMM)Hmgu Tg(Ins1-cre/ERT)1Lphi/0
(involves: C57BL/6N * CD-1)
|
improved glucose tolerance
|
J:215257
|
increased circulating insulin level
|
J:215257
|
increased insulin secretion
|
J:215257
|
Abhd11tm1Esco/Abhd11tm1Esco
(involves: C57BL/6)
|
decreased circulating glucose level
|
J:294591
|
decreased circulating insulin level
|
J:294591
|
improved glucose tolerance
|
J:294591
|
increased insulin sensitivity
|
J:294591
|
Abhd12bem1(IMPC)J/Abhd12bem1(IMPC)J
(C57BL/6NJ-Abhd12bem1(IMPC)J/Mmjax)
|
increased fasting circulating glucose level
|
J:211773
|
Abhd14atm2a(EUCOMM)Wtsi/Abhd14atm2a(EUCOMM)Wtsi
(C57BL/6N-Abhd14atm2a(EUCOMM)Wtsi/Wtsi)
|
improved glucose tolerance
|
J:211773
|
Abhd16atm1a(EUCOMM)Wtsi/Abhd16atm1a(EUCOMM)Wtsi
(C57BL/6N-Abhd16atm1a(EUCOMM)Wtsi/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
Abhd17atm1a(KOMP)Wtsi/Abhd17atm1a(KOMP)Wtsi
(C57BL/6N-Abhd17atm1a(KOMP)Wtsi/Wtsi)
|
improved glucose tolerance
|
J:211773
|
Abtb1em1(IMPC)Ccpcz/Abtb1em1(IMPC)Ccpcz
(C57BL/6N-Abtb1em1(IMPC)Ccpcz/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Acacatm2Sjw/Acacatm2Sjw Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S7/SvEvBrd * C57BL/6J * FVB)
|
abnormal glucose homeostasis
|
J:110200
|
hyperglycemia
|
J:110200
|
increased circulating insulin level
|
J:110200
|
Acacbtm1.1Dejs/Acacbtm1.1Dejs
(B6.Cg-Acacbtm1.1Dejs)
|
abnormal glucose homeostasis
|
J:157000
|
increased skeletal muscle glycogen level
|
J:157000
|
Acacbtm1.2Lowl/Acacbtm1.2Lowl
(involves: 129S6/SvEvTac * FVB/N)
|
increased circulating insulin level
|
J:159285
|
Acacbtm1Sjw/Acacbtm1Sjw
(Not Specified)
|
decreased circulating glucose level
|
J:68427
|
decreased liver glycogen level
|
J:68427
|
Acad12tm1b(EUCOMM)Wtsi/Acad12tm1b(EUCOMM)Wtsi
(C57BL/6N-Acad12tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
Acadltm1Uab/Acadltm1Uab
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
hypoglycemia
|
J:51660
|
Acadmtm1Uab/Acadmtm1Uab
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating glucose level
|
J:115759
|
Acadsdel-J/Acadsdel-J
(involves: BALB/cByJ)
|
hypoglycemia
|
J:14707
|
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * C57BL/6)
|
impaired glucose tolerance
|
J:102010
|
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * Black Swiss * C57BL/6)
|
decreased glycogen level
|
J:106714
|
hypoglycemia
|
J:106714
|
Acadvltm1Zkhu/Acadvltm1Zkhu Tg(Myh6-cre)1Jmk/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCr)
|
decreased circulating glucose level
|
J:208711
|
Acap1tm1.1(KOMP)Vlcg/Acap1tm1.1(KOMP)Vlcg
(B6N(Cg)-Acap1tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Acbd5tm1b(EUCOMM)Wtsi/Acbd5tm1b(EUCOMM)Wtsi
(C57BL/6N-Acbd5tm1b(EUCOMM)Wtsi/Wtsi)
|
improved glucose tolerance
|
J:211773
|
Acetm1Unc/Ace+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased insulin secretion
|
J:128859
|
Acetm3Unc/Ace+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased insulin secretion
|
J:128859
|
Acot7tm1.1Mwol/Acot7tm1.1Mwol Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal glucose homeostasis
|
J:203753
|
Acot11tm1Deco/Acot11tm1Deco
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating glucose level
|
J:182660
|
improved glucose tolerance
|
J:182660
|
Acot13tm1Deco/Acot13tm1Deco
(involves: 129 * C57BL/6)
|
abnormal gluconeogenesis
|
J:183258
|
abnormal glucose homeostasis
|
J:183258
|
improved glucose tolerance
|
J:183258
|
Acox3em1(IMPC)J/Acox3em1(IMPC)J
(C57BL/6NJ-Acox3em1(IMPC)J/Mmjax)
|
impaired glucose tolerance
|
J:211773
|
Acoxlem1(IMPC)Mbp/Acoxlem1(IMPC)Mbp
(C57BL/6NCrl-Acoxlem1(IMPC)Mbp/Mmucd)
|
improved glucose tolerance
|
J:211773
|
Acsl1tm1Rcol/Acsl1tm1Rcol Tg(Fabp4-cre)1Rev/0
(involves: 129P2/OlaHsd * C57BL/6)
|
hypoglycemia
|
J:162996
|
Acsl5tm1.1(KOMP)Vlcg/Acsl5tm1.1(KOMP)Vlcg
(C57BL/6N-Acsl5tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating glucose level
|
J:211773
|
Acsm2tm1.1(KOMP)Vlcg/Acsm2tm1.1(KOMP)Vlcg
(B6N(Cg)-Acsm2tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Acss1tm1Jsak/Acss1tm1Jsak
(B6.129-Acss1tm1Jsak)
|
hypoglycemia
|
J:146647
|
Acta1tm1Jll/Acta1tm1Jll
(involves: 129P2/OlaHsd * Black Swiss)
|
decreased glycogen level
|
J:78070
|
decreased liver glycogen level
|
J:78070
|
decreased skeletal muscle glycogen level
|
J:78070
|
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac Insrtm1Dac/Insrtm1Dac Tg(Camk2a-cre)#Szi/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J * CBA)
|
increased circulating glucose level
|
J:91350
|
increased circulating insulin level
|
J:91350
|
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac Insrtm1Dac/Insrtm1Dac Tg(Hsp70-1-cre)6Arge/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)
|
increased circulating glucose level
|
J:91350
|
increased circulating insulin level
|
J:91350
|
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac Insrtm1Dac/Insrtm1Dac Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * SJL)
|
increased circulating glucose level
|
J:91350
|
increased circulating insulin level
|
J:91350
|
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac Insrtm1Dac/Insrtm1Dac Tg(Syn1-cre)671Jxm/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)
|
increased circulating glucose level
|
J:91350
|
increased circulating insulin level
|
J:91350
|
Actbtm3.1(Sirt1)Npa/Actb+
(involves: 129/Sv * C57BL/6 * C57BL/6J)
|
decreased circulating insulin level
|
J:160212
|
decreased fasting circulating glucose level
|
J:160212
|
improved glucose tolerance
|
J:160212
|
Ad/Ad
(involves: Chr 7 marker stock * Wild stock)
|
increased circulating insulin level
|
J:6095
|
Ad/Ad+
(involves: Chr 7 marker stock * Wild stock)
|
increased circulating insulin level
|
J:6095
|
Adam26atm1.1(KOMP)Vlcg/Adam26atm1.1(KOMP)Vlcg
(C57BL/6N-Adam26atm1.1(KOMP)Vlcg/Ucd)
|
increased circulating glucose level
|
J:211773
|
Adamtsl5tm1b(EUCOMM)Hmgu/Adamtsl5tm1b(EUCOMM)Hmgu
(C57BL/6N-Adamtsl5tm1b(EUCOMM)Hmgu/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Adartm1b(EUCOMM)Wtsi/Adar+
(B6N(Cg)-Adartm1b(EUCOMM)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
Adartm1Knk/Adartm1Knk Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
hyperglycemia
|
J:87714
|
Adcy3Jll/Adcy3+
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased circulating glucose level
|
J:223554
|
decreased circulating insulin level
|
J:223554
|
Adcy9tm1b(EUCOMM)Wtsi/Adcy9+
(C57BL/6N-Adcy9tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
Adcyap1tm1Eid/Adcyap1tm1Eid
(involves: 129S4/SvJae * C57BL/6)
|
hypoglycemia
|
J:73702
|
Adcyap1tm1Nms/Adcyap1tm1Nms
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: C57BL/6))
|
decreased liver glycogen level
|
J:71968
|
hypoglycemia
|
J:71968
|
increased circulating insulin level
|
J:71968
|
Adcyap1r1tm1Bbt/Adcyap1r1tm1Bbt
(involves: 129 * C57BL/6J)
|
decreased circulating insulin level
|
J:62115
|
impaired glucose tolerance
|
J:62115
|
increased circulating insulin level
|
J:62115
|
Adgra1tm1b(EUCOMM)Hmgu/Adgra1tm1b(EUCOMM)Hmgu
(B6N(Cg)-Adgra1tm1b(EUCOMM)Hmgu/J)
|
improved glucose tolerance
|
J:211773
|
Adgrb1tm2a(EUCOMM)Wtsi/Adgrb1tm2a(EUCOMM)Wtsi
(C57BL/6N-Adgrb1tm2a(EUCOMM)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
Adgrb2tm1b(KOMP)Mbp/Adgrb2tm1b(KOMP)Mbp
(B6N(Cg)-Adgrb2tm1b(KOMP)Mbp/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Adgrf5m1Btlr/Adgrf5m1Btlr
(C57BL/6J-Adgrf5m1Btlr)
|
increased circulating glucose level
|
J:225045
|
Adgrf5tm1b(KOMP)Wtsi/Adgrf5tm1b(KOMP)Wtsi
(C57BL/6N-Adgrf5tm1b(KOMP)Wtsi/Tcp)
|
increased fasting circulating glucose level
|
J:211773
|
Adigtm1.1(KOMP)Vlcg/Adigtm1.1(KOMP)Vlcg
(B6J.B6N-Adigtm1.1(KOMP)Vlcg)
|
decreased circulating insulin level
|
J:304292
|
improved glucose tolerance
|
J:304292
|
increased insulin sensitivity
|
J:304292
|
Adigtm1.1(KOMP)Vlcg/Adigtm1.1(KOMP)Vlcg Lepob/Lepob
(B6.Cg-Adigtm1.1(KOMP)Vlcg Lepob)
|
impaired glucose tolerance
|
J:304292
|
Adip1LG/J/? Capn10tm1Chev/Capn10+
((B6.129-Capn10tm1Chev x LG/J)F1)
|
decreased circulating glucose level
|
J:153477
|
Adip1SM/J/? Capn10tm1Chev/Capn10+
((B6.129-Capn10tm1Chev x SM/J)F1)
|
decreased circulating glucose level
|
J:153477
|
Adipoqtm1Far/Adipoqtm1Far
(involves: C57BL/6J)
|
impaired glucose tolerance
|
J:111346
|
Adipoqtm1Far/Adipoqtm1Far
(involves: 129S4/SvJae * C57BL/6J)
|
impaired glucose tolerance
|
J:111346
|
increased circulating glucose level
|
J:111346
|
Adipoqtm1Far/Adipoqtm1Far Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal glucose tolerance
|
J:111346
|
decreased circulating glucose level
|
J:111346
|
Adipoqtm1Ish/Adipoq+ Bglap/Bglap2tm1Kry/Bglap+
(involves: 129S7/SvEvBrd)
|
insulin resistance
|
J:126780
|
Adipoqtm1Ish/Adipoq+ Bglap/Bglap2tm1Kry/Bglap2+
(involves: 129S7/SvEvBrd)
|
insulin resistance
|
J:126780
|
Adipoqtm1Ish/Adipoqtm1Ish
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal glucose homeostasis
|
J:199264
|
decreased insulin secretion
|
J:199264
|
hyperglycemia
|
J:77479,
J:103106
|
impaired glucose tolerance
|
J:199264
|
increased circulating glucose level
|
J:106599
|
increased circulating insulin level
|
J:77479
|
insulin resistance
|
J:77479
|
Adipoqtm1Ish/Adipoqtm1Ish Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6J)
|
impaired glucose tolerance
|
J:199264
|
increased circulating glucose level
|
J:199264
|
Adipoqtm1Pesch/Adipoqtm1Pesch
(involves: 129S7/SvEvBrd)
|
abnormal gluconeogenesis
|
J:107486
|
impaired glucose tolerance
|
J:107486
|
Adipoqtm1Pesch/Adipoqtm1Pesch Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6J)
|
impaired glucose tolerance
|
J:107486
|
Adipoqtm1Tka/Adipoq+
(involves: 129S4/SvJae * C57BL/6)
|
impaired glucose tolerance
|
J:77876
|
insulin resistance
|
J:77876
|
Adipoqtm1Tka/Adipoqtm1Tka
(involves: 129S4/SvJae * C57BL/6)
|
impaired glucose tolerance
|
J:77876
|
insulin resistance
|
J:77876
|
Adipor1tm1Dgen/Adipor1tm1Dgen
(B6.129P2-Adipor1tm1Dgen/Mmnc)
|
impaired glucose tolerance
|
J:122027
|
Adipor1tm1Tka/Adipor1tm1Tka
(involves: 129S4/SvJae * C57BL/6)
|
abnormal glucose homeostasis
|
J:117919
|
hyperglycemia
|
J:117919
|
impaired glucose tolerance
|
J:117919
|
increased circulating glucose level
|
J:117919
|
increased circulating insulin level
|
J:117919
|
insulin resistance
|
J:117919
|
Adipor1tm1Tka/Adipor1tm1Tka Adipor2tm1Tka/Adipor2tm1Tka
(involves: 129S4/SvJae * C57BL/6)
|
abnormal circulating glucose level
|
J:117919
|
abnormal gluconeogenesis
|
J:117919
|
abnormal glucose homeostasis
|
J:117919
|
hyperglycemia
|
J:117919
|
impaired glucose tolerance
|
J:117919
|
insulin resistance
|
J:117919
|
Adipor1tm2Tka/Adipor1tm2Tka Tg(Ckmm-cre)5Khn/0
(B6.Cg-Adipor1tm2Tka Tg(Ckmm-cre)5Khn)
|
abnormal glucose homeostasis
|
J:159462
|
increased circulating glucose level
|
J:159462
|
increased circulating insulin level
|
J:159462
|
insulin resistance
|
J:159462
|
Adipor2tm1Dgen/Adipor2tm1Dgen
(B6.129P2-Adipor2tm1Dgen)
|
decreased circulating insulin level
|
J:122027
|
improved glucose tolerance
|
J:122027
|
Adipor2tm1Tka/Adipor2tm1Tka
(involves: 129S4/SvJae * C57BL/6)
|
abnormal glucose homeostasis
|
J:117919
|
hyperglycemia
|
J:117919
|
impaired glucose tolerance
|
J:117919
|
increased circulating insulin level
|
J:117919
|
insulin resistance
|
J:117919
|
Adipor2tm2Dgen/Adipor2tm2Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal glucose homeostasis
|
J:129554
|
decreased circulating insulin level
|
J:129554
|
increased circulating glucose level
|
J:129554
|
Adora2aem1(IMPC)H/Adora2aem1(IMPC)H
(C57BL/6N-Adora2aem1(IMPC)H/H)
|
increased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Adora2btm1.1(KOMP)Vlcg/Adora2b+
(B6N(Cg)-Adora2btm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Adora2btm1.1(KOMP)Vlcg/Adora2btm1.1(KOMP)Vlcg
(B6N(Cg)-Adora2btm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal glucose homeostasis
|
J:87718
|
decreased skeletal muscle glycogen level
|
J:87718
|
hyperglycemia
|
J:87718
|
impaired glucose tolerance
|
J:87718
|
increased circulating insulin level
|
J:87718
|
increased liver glycogen level
|
J:87718
|
insulin resistance
|
J:87718
|
Adra2am1Btlr/Adra2am1Btlr
(C57BL/6J-Adra2am1Btlr)
|
decreased circulating glucose level
|
J:267700
|
increased circulating insulin level
|
J:267700
|
Adra2am2Btlr/Adra2am2Btlr
(C57BL/6J-Adra2am2Btlr)
|
decreased circulating glucose level
|
J:267701
|
Adra2atm1.1(KOMP)Vlcg/Adra2atm1.1(KOMP)Vlcg
(C57BL/6N-Adra2atm1.1(KOMP)Vlcg/Ucd)
|
decreased fasting circulating glucose level
|
J:211773
|
improved glucose tolerance
|
J:211773
|
Adra2atm1Bkk/Adra2atm1Bkk
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal glucose homeostasis
|
J:130781
|
hypoglycemia
|
J:130781
|
Adrb2tm1Kry/Adrb2+ Lepob/Lep+ Tg(Col1a1-cre)1Kry/0
(involves: C57BL/6 * C57BL/10J * FVB)
|
decreased circulating glucose level
|
J:145998
|
increased circulating insulin level
|
J:145998
|
Adrb2tm1Kry/Adrb2tm1Kry Tg(Col1a1-cre)1Kry/0
(involves: FVB)
|
abnormal insulin secretion
|
J:145998
|
decreased circulating glucose level
|
J:145998
|
increased circulating insulin level
|
J:145998
|
Afap1l2tm1b(KOMP)Wtsi/Afap1l2tm1b(KOMP)Wtsi
(C57BL/6N-Afap1l2tm1b(KOMP)Wtsi/Ucd)
|
improved glucose tolerance
|
J:211773
|
Afmidtm1a(EUCOMM)Wtsi/Afmidtm1a(EUCOMM)Wtsi
(C57BL/6N-Afmidtm1a(EUCOMM)Wtsi/H)
|
hyperglycemia
|
J:226537
|
Afmidtm1b(EUCOMM)Wtsi/Afmid+
(C57BL/6N-Afmidtm1b(EUCOMM)Wtsi/H)
|
impaired glucose tolerance
|
J:226537
|
Afmidtm1b(EUCOMM)Wtsi/Afmidtm1b(EUCOMM)Wtsi
(C57BL/6N-Afmidtm1b(EUCOMM)Wtsi/H)
|
decreased insulin secretion
|
J:226537
|
impaired glucose tolerance
|
J:226537
|
increased circulating glucose level
|
J:211773,
J:226537
|
Afptm1(Cebpa)Ndw/Afp+
(involves: 129S7/SvEvBrd)
|
increased liver glycogen level
|
J:103404
|
Agap2tm1.1Kye/Agap2tm1.1Kye
(Not Specified)
|
abnormal gluconeogenesis
|
J:174775
|
hyperglycemia
|
J:174775
|
increased insulin sensitivity
|
J:174775
|
insulin resistance
|
J:174775
|
Agap2tm1Kye/Agap2tm1Kye Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA/2)
|
abnormal gluconeogenesis
|
J:174775
|
hyperglycemia
|
J:174775
|
impaired glucose tolerance
|
J:174775
|
increased circulating insulin level
|
J:174775
|
insulin resistance
|
J:174775
|
Agertm1.1Arnd/Agertm1.1Arnd
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating glucose level
|
J:82491
|
Agertm1.1Hyam/Ager+ Tg(Ins2-Nos2)40Okam/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA/2)
|
hyperglycemia
|
J:116040
|
Agertm1.1Hyam/Agertm1.1Hyam
(involves: 129P2/OlaHsd * C57BL/6J * CD-1)
|
increased circulating glucose level
|
J:116507
|
Agertm1.1Hyam/Agertm1.1Hyam Tg(Ins2-Nos2)40Okam/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA/2)
|
hyperglycemia
|
J:116040
|
Agltm1a(EUCOMM)Wtsi/Agltm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
hypoglycemia
|
J:212003
|
increased cardiac muscle glycogen level
|
J:212003
|
increased liver glycogen level
|
J:212003
|
increased skeletal muscle glycogen level
|
J:212003
|
Agltm1b(EUCOMM)Wtsi/Agltm1b(EUCOMM)Wtsi
(C57BL/6N-Agltm1b(EUCOMM)Wtsi/H)
|
decreased circulating glucose level
|
J:211773
|
impaired glucose tolerance
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Agltm1Geno/Agltm1Geno
(C57BL/6J-Agltm1Geno)
|
decreased circulating glucose level
|
J:218471
|
decreased fasting circulating glucose level
|
J:218471
|
increased brain glycogen level
|
J:218471
|
increased cardiac muscle glycogen level
|
J:218471
|
increased glycogen level
|
J:218471
|
increased liver glycogen level
|
J:218471
|
increased skeletal muscle glycogen level
|
J:218471
|
Ago2tm1.1Tara/Ago2tm1.1Tara Lepob/Lepob Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
decreased circulating glucose level
|
J:210552
|
decreased circulating insulin level
|
J:210552
|
improved glucose tolerance
|
J:210552
|
increased circulating insulin level
|
J:210552
|
Ago2tm1.1Tara/Ago2tm1.1Tara Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
improved glucose tolerance
|
J:210552
|
Agpat1tm1.1(KOMP)Vlcg/Agpat1+
(B6N(Cg)-Agpat1tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased urine glucose level
|
J:211773
|
Agpat1tm1Garg/Agpat1tm1Garg
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating glucose level
|
J:250301
|
hypoglycemia
|
J:250301
|
impaired gluconeogenesis
|
J:250301
|
Agpat2Gt(OST438470)Lex/Agpat2Gt(OST438470)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
hyperglycemia
|
J:186035
|
increased circulating glucose level
|
J:186035
|
increased circulating insulin level
|
J:186035
|
Agpat2tm1Garg/Agpat2tm1Garg
(involves: 129S6/SvEvTac)
|
abnormal glucose homeostasis
|
J:146649
|
hyperglycemia
|
J:146649
|
improved glucose tolerance
|
J:231617
|
increased circulating glucose level
|
J:231617
|
increased circulating insulin level
|
J:231617,
J:146649
|
insulin resistance
|
J:231617,
J:146649
|
Agpat2tm1Garg/Agpat2tm1Garg Mogat1tm1Far/Mogat1tm1Far
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
improved glucose tolerance
|
J:231617
|
increased circulating glucose level
|
J:231617
|
increased circulating insulin level
|
J:231617
|
insulin resistance
|
J:231617
|
Agpat4tm1b(KOMP)Wtsi/Agpat4tm1b(KOMP)Wtsi
(C57BL/6N-Agpat4tm1b(KOMP)Wtsi/H)
|
increased fasting circulating glucose level
|
J:211773
|
Agrptm2(DTR)Rpa/Agrp+ Lepob/Lepob
(involves: 129S4/SvJaeSor * C57BL/6)
|
improved glucose tolerance
|
J:181947
|
Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd)
|
abnormal circulating insulin level
|
J:105210
|
abnormal glucose homeostasis
|
J:105210
|
increased insulin sensitivity
|
J:105210
|
Agtraptm1Tamk/Agtraptm1Tamk
(involves: C57BL/6N)
|
increased circulating insulin level
|
J:263253
|
insulin resistance
|
J:263253
|
Ahnaktm1b(KOMP)Mbp/Ahnak+
(C57BL/6N-Ahnaktm1b(KOMP)Mbp/H)
|
improved glucose tolerance
|
J:211773
|
Ahsgtm1Mbl/Ahsgtm1Mbl
(B6.129-Ahsgtm1Mbl)
|
decreased circulating insulin level
|
J:78087
|
improved glucose tolerance
|
J:78087
|
increased insulin sensitivity
|
J:78087
|
Aidatm1.1Scli/Aidatm1.1Scli
(involves: C57BL/6 * FVB/N)
|
hyperglycemia
|
J:262001
|
increased circulating insulin level
|
J:262001
|
increased liver glycogen level
|
J:262001
|
insulin resistance
|
J:262001
|
Aifm1tm2Pngr/Y Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
abnormal glucose homeostasis
|
J:113016
|
Aifm3em1(IMPC)Rbrc/Aifm3em1(IMPC)Rbrc
(Not Specified)
|
increased fasting circulating glucose level
|
J:211773
|
Ak1tm1Bew/Ak1tm1Bew
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal glucose homeostasis
|
J:66101
|
Akap5tm1.1Jsco/Akap5tm1.1Jsco
(involves: 129S * C57BL/6)
|
decreased circulating insulin level
|
J:190017
|
decreased insulin secretion
|
J:190017
|
improved glucose tolerance
|
J:190017
|
increased insulin sensitivity
|
J:190017
|
Akap5tm1Gsm/Akap5tm1Gsm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased circulating insulin level
|
J:190017
|
Akap5tm1Jsco/Akap5tm1Jsco Tg(Ins2-cre)25Mgn/0
(involves: 129S * C57BL/6 * DBA)
|
decreased circulating insulin level
|
J:190017
|
impaired glucose tolerance
|
J:190017
|
increased insulin secretion
|
J:190017
|
Akap5tm1Mdaq/Akap5tm1Mdaq
(involves: 129 * C57BL/6 * C57BL/6J)
|
decreased circulating insulin level
|
J:190017
|
decreased insulin secretion
|
J:190017
|
improved glucose tolerance
|
J:190017
|
increased insulin sensitivity
|
J:190017
|
Akap9tm1a(KOMP)Wtsi/Akap9+
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating glucose level
|
J:213427
|
Akr1b7tm1.1Anm/Akr1b7tm1.1Anm
(involves: 129)
|
increased circulating insulin level
|
J:208505
|
insulin resistance
|
J:208505
|
Akr1b8tm1.1(KOMP)Vlcg/Akr1b8tm1.1(KOMP)Vlcg
(B6N(Cg)-Akr1b8tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Akr1d1tm1.1(KOMP)Vlcg/Akr1d1tm1.1(KOMP)Vlcg
(B6N(Cg)-Akr1d1tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Akt1tm1Nhy/Akt1+ Akt2tm1Rsg/Akt2tm1Rsg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ)
|
decreased insulin secretion
|
J:149156
|
hyperglycemia
|
J:149156
|
impaired glucose tolerance
|
J:149156
|
increased circulating insulin level
|
J:149156
|
Akt1tm1Nhy/Akt1+ Akt2tm1Rsg/Akt2tm1Rsg Akt3tm1Nhy/Akt3tm1Nhy
(involves: 129/Sv * C57BL/6 * DBA/1LacJ)
|
hyperglycemia
|
J:149156
|
Akt1tm1Nhy/Akt1+ Akt2tm1Rsg/Akt2tm1Rsg Ptentm1Ppp/Pten+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ)
|
impaired glucose tolerance
|
J:149156
|
increased circulating insulin level
|
J:149156
|
Akt1tm2.1Mbb/Akt1tm2.1Mbb
(involves: 129S4/SvJae * C57BL/6J * FVB/N)
|
abnormal gluconeogenesis
|
J:182721
|
abnormal glucose homeostasis
|
J:182721
|
improved glucose tolerance
|
J:182721
|
increased insulin sensitivity
|
J:182721
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd * C57BL/6)
|
hyperglycemia
|
J:71491
|
impaired glucose tolerance
|
J:71491
|
increased circulating insulin level
|
J:71491
|
insulin resistance
|
J:71491
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd)
|
hyperglycemia
|
J:160759
|
impaired glucose tolerance
|
J:160759
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(B6.129P2-Akt2tm1.1Mbb)
|
decreased circulating glucose level
|
J:155432
|
increased circulating insulin level
|
J:155432
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb Lepob/Lepob
(B6.Cg-Lepob Akt2tm1.1Mbb)
|
increased circulating glucose level
|
J:155432
|
increased circulating insulin level
|
J:155432
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb Ptentm1Hwu/Ptentm1Hwu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)
|
hyperglycemia
|
J:160759
|
impaired glucose tolerance
|
J:160759
|
Akt2tm1.2Mbb/Akt2tm1.2Mbb Lepob/Lepob Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL)
|
increased circulating glucose level
|
J:155432
|
Akt2tm1Hem/Akt2tm1Hem
(involves: 129P2/OlaHsd * C57BL/6)
|
hyperglycemia
|
J:114675
|
impaired glucose tolerance
|
J:114675
|
increased circulating insulin level
|
J:114675
|
insulin resistance
|
J:114675
|
Akt2tm1Hem/Akt2tm1Hem Akt3tm1Hem/Akt3tm1Hem
(involves: 129P2/OlaHsd * C57BL/6)
|
hyperglycemia
|
J:114675
|
impaired glucose tolerance
|
J:114675
|
increased circulating insulin level
|
J:114675
|
insulin resistance
|
J:114675
|
Akt2tm1Rsg/Akt2tm1Rsg
(DBA/1LacJ-Akt2tm1Rsg)
|
abnormal glucose homeostasis
|
J:84606
|
decreased circulating insulin level
|
J:84606
|
hyperglycemia
|
J:84606
|
impaired glucose tolerance
|
J:84606
|
increased circulating insulin level
|
J:84606
|
insulin resistance
|
J:84606
|
Akt2tm1Rsg/Akt2tm1Rsg
(involves: C57BL/6 * DBA/1LacJ)
|
impaired glucose tolerance
|
J:149156
|
increased circulating insulin level
|
J:149156
|
insulin resistance
|
J:149156
|
Akt2tm1Rsg/Akt2tm1Rsg Akt3tm1Nhy/Akt3tm1Nhy
(involves: 129/Sv * C57BL/6 * DBA/1LacJ)
|
impaired glucose tolerance
|
J:149156
|
Akt2tm1Rsg/Akt2tm1Rsg Ptentm1Ppp/Pten+
(involves: 129S1/Sv * C57BL/6 * DBA/1LacJ)
|
decreased circulating insulin level
|
J:149156
|
impaired glucose tolerance
|
J:149156
|
Albtm1(cre/ERT2)Mtz/Albtm1(cre/ERT2)Mtz Slc2a2tm2Thor/Slc2a2tm2Thor
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal circulating glucose level
|
J:197607
|
abnormal glucose homeostasis
|
J:197607
|
abnormal glycogen homeostasis
|
J:197607
|
decreased insulin secretion
|
J:197607
|
impaired glucose tolerance
|
J:197607
|
increased liver glycogen level
|
J:197607
|
Aldh1b1tm1.1(KOMP)Vlcg/Aldh1b1tm1.1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac * CBA)
|
decreased insulin secretion
|
J:232360
|
hyperglycemia
|
J:232360
|
impaired glucose tolerance
|
J:232360
|
increased glucagon secretion
|
J:232360
|
increased insulin secretion
|
J:232360
|
insulin resistance
|
J:232360
|
Aldh1b1tm1Vvas/Aldh1b1tm1Vvas
(B6J.Cg-Aldh1b1tm1Vvas)
|
increased fasting circulating glucose level
|
J:228677
|
Alg2tm1.1(KOMP)Vlcg/Alg2+
(B6N(Cg)-Alg2tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Alkbh7tm1.1Klng/Alkbh7tm1.1Klng
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal glucose homeostasis
|
J:298649
|
decreased fasting circulating glucose level
|
J:198968
|
increased circulating insulin level
|
J:198968
|
increased hepatic glucose production
|
J:198968
|
increased insulin sensitivity
|
J:198968
|
Alms1bbb/Alms1bbb
(C57BL/6JSfdAnu-Alms1bbb/Anu)
|
hyperglycemia
|
J:104190
|
increased circulating insulin level
|
J:104190
|
Alms1foz/Alms1foz
(involves: NOD)
|
hyperglycemia
|
J:107058
|
increased circulating insulin level
|
J:107058
|
insulin resistance
|
J:107058
|
Alms1Gt(XH152)Byg/Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
hyperglycemia
|
J:100403
|
increased circulating insulin level
|
J:100403
|
Alms1L2131X/Alms1L2131X
(involves: C57BL/6 * NOD)
|
increased circulating insulin level
|
J:118221
|
Alms1m2Btlr/Alms1m2Btlr
(C57BL/6J-Alms1m2Btlr)
|
impaired glucose tolerance
|
J:264648
|
Alms1m3Btlr/Alms1m3Btlr
(C57BL/6J-Alms1m3Btlr)
|
impaired glucose tolerance
|
J:264649
|
increased circulating insulin level
|
J:264649
|
increased fasting circulating glucose level
|
J:264649
|
Alox15tm1.1Nadl/Alox15tm1.1Nadl Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA)
|
improved glucose tolerance
|
J:224344
|
increased insulin secretion
|
J:224344
|
Alx3tm1Hubr/Alx3+
(involves: 129P2/OlaHsd)
|
impaired glucose tolerance
|
J:166436
|
increased circulating glucose level
|
J:166436
|
Alx3tm1Hubr/Alx3tm1Hubr
(involves: 129P2/OlaHsd)
|
decreased insulin secretion
|
J:166436
|
impaired glucose tolerance
|
J:166436
|
increased circulating insulin level
|
J:166436
|
increased fasting circulating glucose level
|
J:166436
|
insulin resistance
|
J:166436
|
Anapc2tm1Kna/Anapc2tm2Kna Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased liver glycogen level
|
J:87782
|
Angptl2tm1Yo/Angptl2tm1Yo
(B6.Cg-Angptl2tm1Yo)
|
improved glucose tolerance
|
J:152387
|
increased insulin sensitivity
|
J:152387
|
Angptl6tm1Yo/Angptl6tm1Yo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
hyperglycemia
|
J:97552
|
increased circulating insulin level
|
J:97552
|
insulin resistance
|
J:97552
|
Ank2tm2.1Bnt/Ank2+
(STOCK Ank2tm2Bnt/J)
|
impaired glucose tolerance
|
J:222913
|
Ank2tm2.1Bnt/Ank2tm2.1Bnt
(STOCK Ank2tm2Bnt/J)
|
abnormal gluconeogenesis
|
J:222913
|
impaired glucose tolerance
|
J:222913
|
increased circulating glucose level
|
J:222913
|
insulin resistance
|
J:222913
|
Ank2tm3.1Bnt/Ank2+
(B6.129(C)-Ank2tm3.1Bnt/J)
|
impaired glucose tolerance
|
J:222913
|
increased circulating glucose level
|
J:222913
|
Ank2tm3.1Bnt/Ank2tm3.1Bnt
(B6.129(C)-Ank2tm3.1Bnt/J)
|
abnormal gluconeogenesis
|
J:222913
|
abnormal glucose homeostasis
|
J:222913
|
decreased circulating insulin level
|
J:222913
|
decreased insulin secretion
|
J:222913
|
impaired glucose tolerance
|
J:222913
|
increased circulating glucose level
|
J:222913
|
insulin resistance
|
J:222913
|
Ankhd1tm1a(KOMP)Wtsi/Ankhd1tm1a(KOMP)Wtsi
(C57BL/6N-Ankhd1tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
Ankib1tm1b(EUCOMM)Hmgu/Ankib1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ankib1tm1b(EUCOMM)Hmgu/H)
|
increased fasting circulating glucose level
|
J:211773
|
Ankrd26Gt(XK525)Byg/Ankrd26Gt(XK525)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating insulin level
|
J:130984
|
insulin resistance
|
J:130984
|
anx/anx
(B6C3Fe a/a-anx/J)
|
hypoglycemia
|
J:7689
|
Anxa1tm1Rjf/Anxa1tm1Rjf
(Not Specified)
|
increased circulating insulin level
|
J:115806
|
Anxa7tm1Pll/Anxa7+
(Not Specified)
|
decreased insulin secretion
|
J:58572
|
Ap1m2tm1.1Ohno/Ap1m2tm1.1Ohno
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
decreased circulating glucose level
|
J:226582
|
Ap1s2em1(IMPC)Mbp/Ap1s2em1(IMPC)Mbp
(C57BL/6N-Ap1s2em1(IMPC)Mbp/MbpMmucd)
|
decreased fasting circulating glucose level
|
J:211773
|
Ap3s1tm1b(EUCOMM)Hmgu/Ap3s1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ap3s1tm1b(EUCOMM)Hmgu/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Ieg)
|
impaired glucose tolerance
|
J:211773
|
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Apbb2M1Btlr/Apbb2M1Btlr
(C57BL/6J-Apbb2M1Btlr)
|
impaired glucose tolerance
|
J:265064
|
Apbb2m2Btlr/Apbb2m2Btlr
(C57BL/6J-Apbb2m2Btlr)
|
impaired glucose tolerance
|
J:265072
|
Apmaptm1.2Jgbs/Apmaptm1.2Jgbs
(B6.129P2-Apmaptm1.2Jgbs)
|
decreased circulating glucose level
|
J:247647
|
improved glucose tolerance
|
J:247647
|
increased insulin sensitivity
|
J:247647
|
Apoa2tm1Bres/Apoa2tm1Bres
(involves: 129S4/SvJae)
|
decreased circulating glucose level
|
J:37250
|
decreased circulating insulin level
|
J:37250
|
Apobtm2Sgy/Apobtm2Sgy Apoetm1Unc/Apoetm1Unc Lepob/Lepob
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
hyperglycemia
|
J:133453
|
impaired glucose tolerance
|
J:133453
|
increased circulating insulin level
|
J:133453
|
Apobtm2Sgy/Apobtm2Sgy Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased circulating insulin level
|
J:227165
|
Apobtm2Sgy/Apobtm2Sgy Ldlrtm1Her/Ldlrtm1Her Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating insulin level
|
J:133453
|
Apobtm2Sgy/Apobtm2Sgy Ldlrtm1Her/Ldlrtm1Her Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
impaired glucose tolerance
|
J:141333
|
increased circulating glucose level
|
J:141333
|
increased circulating insulin level
|
J:141333
|
Apobtm2Sgy/Apobtm2Sgy Ldlrtm1Her/Ldlrtm1Her Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)
|
abnormal fasting circulating glucose level
|
J:227165
|
increased circulating insulin level
|
J:227165
|
Apoc3tm1Unc/Apoc3tm1Unc
(B6.129-Apoc3tm1Unc/J)
|
increased circulating glucose level
|
J:105136
|
insulin resistance
|
J:105136
|
Apoc4tm1.1(KOMP)Mbp/Apoc4tm1.1(KOMP)Mbp
(C57BL/6N-Apoc4tm1.1(KOMP)Mbp/Ieg)
|
impaired glucose tolerance
|
J:211773
|
Apoetm1.1Mae/Apoetm1.1Mae Tg(Fabp4-cre)1Rev/0
(B6.Cg-Apoetm1.1Mae Tg(Fabp4-cre)1Rev)
|
decreased circulating glucose level
|
J:219838
|
decreased circulating insulin level
|
J:219838
|
improved glucose tolerance
|
J:219838
|
increased insulin sensitivity
|
J:219838
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
|
decreased circulating glucose level
|
J:73202
|
Apoetm1Unc/Apoetm1Unc Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
decreased circulating insulin level
|
J:184647
|
impaired glucose tolerance
|
J:184647
|
increased circulating glucose level
|
J:184647
|
insulin resistance
|
J:184647
|
Apoetm1Unc/Apoetm1Unc Fabp4tm1Brsp/Fabp4tm1Brsp Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Apoetm1Unc)
|
decreased circulating glucose level
|
J:102223
|
improved glucose tolerance
|
J:102223
|
increased insulin sensitivity
|
J:102223
|
Apoetm1Unc/Apoetm1Unc Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating glucose level
|
J:143903
|
Apoetm3(APOE*4)Mae/Apoetm3(APOE*4)Mae
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal glucose homeostasis
|
J:151284
|
impaired glucose tolerance
|
J:151284
|
Appl1Gt(RRS819)Byg/Appl1Gt(RRS819)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal hepatic glucose production
|
J:211794
|
impaired glucose tolerance
|
J:211794
|
increased circulating insulin level
|
J:211794
|
increased fasting circulating glucose level
|
J:211794
|
insulin resistance
|
J:211794
|
Appl2tm1Smoc/Appl2tm1Smoc Tg(Ckmm-cre)5Khn/0
(involves: FVB)
|
improved glucose tolerance
|
J:230004
|
increased insulin sensitivity
|
J:230004
|
Aqp1tm1Ask/Aqp1tm1Ask Aqp7tm1.1Suc/Aqp7tm1.1Suc
(involves: 129S2/SvPas * C57BL/6J)
|
increased urine glucose level
|
J:102454
|
Aqp1tm1b(EUCOMM)Wtsi/Aqp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Aqp1tm1b(EUCOMM)Wtsi/H)
|
impaired glucose tolerance
|
J:211773
|
Aqp7tm1.1Suc/Aqp7tm1.1Suc
(involves: 129S2/SvPas * C57BL/6J)
|
increased urine glucose level
|
J:102454
|
Aqp7tm1Chan/Aqp7tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating insulin level
|
J:125011
|
increased insulin secretion
|
J:125011
|
Aqp7tm1Tfun/Aqp7tm1Tfun
(B6N.129X1-Aqp7tm1Tfun)
|
hypoglycemia
|
J:95278
|
Aqp9tm1Nlsn/Aqp9tm1Nlsn Leprdb/Leprdb
(involves: 129S1/Sv * C57BL/6 * C57BLKS/J)
|
decreased circulating glucose level
|
J:123742
|
Artm1Chc/Y Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
hyperglycemia
|
J:98775
|
impaired glucose tolerance
|
J:98775
|
increased circulating glucose level
|
J:98775
|
increased circulating insulin level
|
J:98775
|
insulin resistance
|
J:98775
|
Artm1Verh/Y Tg(Fabp4-cre)1Rev/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
hyperglycemia
|
J:196857
|
impaired glucose tolerance
|
J:196857
|
increased circulating insulin level
|
J:196857
|
insulin resistance
|
J:196857
|
Arel1tm1b(EUCOMM)Hmgu/Arel1tm1b(EUCOMM)Hmgu
(C57BL/6N-Arel1tm1b(EUCOMM)Hmgu/Mhzh)
|
increased fasting circulating glucose level
|
J:211773
|
Arf2tm1.1(KOMP)Wtsi/Arf2tm1.1(KOMP)Wtsi
(B6N(Cg)-Arf2tm1.1(KOMP)Wtsi/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Arfgef3tm1Hong/Arfgef3tm1Hong
(129.129P2(B6)-Arfgef3tm1Hong)
|
abnormal glucose homeostasis
|
J:216529
|
hyperglycemia
|
J:216529
|
impaired glucose tolerance
|
J:216529
|
increased circulating insulin level
|
J:216529
|
increased insulin secretion
|
J:216529
|
insulin resistance
|
J:216529
|
Arhgap17tm1b(EUCOMM)Wtsi/Arhgap17tm1b(EUCOMM)Wtsi
(C57BL/6N-Arhgap17tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
improved glucose tolerance
|
J:211773
|
Arhgef10tm1.1(KOMP)Vlcg/Arhgef10tm1.1(KOMP)Vlcg
(B6N(Cg)-Arhgef10tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Arhgef11tm1.1Mak/Arhgef11tm1.1Mak
(B6.129P2(C)-Arhgef11tm1.1Mak)
|
abnormal glucose homeostasis
|
J:233950
|
Arid1bem1(IMPC)Tcp/Arid1b+
(C57BL/6NCrl-Arid1bem1(IMPC)Tcp/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
Arid3atm1b(KOMP)Wtsi/Arid3a+
(B6N(Cg)-Arid3atm1b(KOMP)Wtsi/J)
|
increased circulating insulin level
|
J:211773
|
Arnt2em1Btlr/Arnt2em1Btlr
(C57BL/6J-Arnt2em1Btlr)
|
impaired glucose tolerance
|
J:268298
|
increased circulating insulin level
|
J:268298
|
increased fasting circulating glucose level
|
J:268298
|
Arntltm1.2Shbi/Arntltm1.2Shbi
(involves: C57BL/6J)
|
abnormal gluconeogenesis
|
J:177865
|
abnormal glucose homeostasis
|
J:177865
|
decreased circulating insulin level
|
J:177865
|
decreased insulin secretion
|
J:177865
|
hyperglycemia
|
J:177865
|
impaired glucose tolerance
|
J:177865
|
Arntltm1Bra/Arntltm1Bra
(involves: 129)
|
abnormal glucose homeostasis
|
J:131694
|
impaired gluconeogenesis
|
J:131694
|
increased insulin sensitivity
|
J:131694
|
Arntltm1Bra/Arntltm1Bra
(involves: 129/Sv * C57BL/6)
|
decreased circulating glucose level
|
J:135933
|
decreased insulin secretion
|
J:162641
|
Arntltm2Bra/Arntltm2Bra Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * C57BL/6J * CBA * ICR)
|
decreased insulin secretion
|
J:162641
|
hyperglycemia
|
J:162641
|
impaired glucose tolerance
|
J:162641
|
Arpc5ltm1.1(KOMP)Vlcg/Arpc5l+
(B6N(Cg)-Arpc5ltm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Arrdc3Gt(CSE151)Byg/Arrdc3+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating glucose level
|
J:179646
|
Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal glucose homeostasis
|
J:179646
|
decreased circulating glucose level
|
J:179646
|
decreased circulating insulin level
|
J:179646
|
increased insulin sensitivity
|
J:179646
|
ArtlesC57BL/6J/?
(involves: C57BL/6J * CAST/Ei)
|
increased circulating insulin level
|
J:70961
|
ArtlesCAST/EiJ/?
(involves: C57BL/6J * CAST/Ei)
|
decreased circulating insulin level
|
J:70961
|
Arv1tm1.2Geno/Arv1tm1.2Geno
(involves: C57BL/6 * C57BL/6J)
|
decreased fasting circulating glucose level
|
J:263695
|
improved glucose tolerance
|
J:263695
|
increased insulin sensitivity
|
J:263695
|
Arv1tm1.2Radr/Arv1tm1.2Radr
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)
|
decreased fasting circulating glucose level
|
J:241193
|
hypoglycemia
|
J:241193
|
improved glucose tolerance
|
J:241193
|
Arxtm1Gldn/Arxtm1Gldn Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss Tg(Ins2-cre)23Herr/0
(involves: 129 * Black Swiss * C57BL/6 * CBA/J * SJL)
|
hyperglycemia
|
J:177838
|
Arxtm1Pgr/Y
(involves: 129/Sv * NMRI)
|
hypoglycemia
|
J:86206
|
Asb7em1(IMPC)Ccpcz/Asb7em1(IMPC)Ccpcz
(C57BL/6N-Asb7em1(IMPC)Ccpcz/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Asf1atm1b(KOMP)Wtsi/Asf1a+
(B6N(Cg)-Asf1atm1b(KOMP)Wtsi/2J)
|
increased circulating insulin level
|
J:211773
|
Ash1ltm2b(EUCOMM)Hmgu/Ash1l+
(C57BL/6N-Ash1ltm2b(EUCOMM)Hmgu/Nju)
|
increased fasting circulating glucose level
|
J:211773
|
Aspatm1b(EUCOMM)Wtsi/Aspatm1b(EUCOMM)Wtsi
(C57BL/6N-Aspatm1b(EUCOMM)Wtsi/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Asxl1tm1a(EUCOMM)Wtsi/Asxl1+
(B6Dnk;B6Brd;B6N-Asxl1tm1a(EUCOMM)Wtsi Tyrc-Brd/WtsiH)
|
decreased circulating glucose level
|
J:175295
|
Ate1tm1Avar/Ate1tm2.1Avar Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased circulating glucose level
|
J:155421
|
Atf2tm1b(EUCOMM)Hmgu/Atf2+
(C57BL/6N-Atf2tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Atf2tm1Sis/Atf2+ Creb5tm1Sis/Creb5+
(involves: C57BL/6 * CBA)
|
improved glucose tolerance
|
J:156376
|
increased insulin sensitivity
|
J:156376
|
Atf3tm1.2Kitab/Atf3tm1.2Kitab Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * CBA)
|
decreased circulating glucose level
|
J:231262
|
improved glucose tolerance
|
J:231262
|
increased insulin sensitivity
|
J:231262
|
Atf4tm1Kry/Atf4tm1Kry Tg(Col1a1-cre)1Kry/0
(involves: C57BL/6J * FVB)
|
abnormal glucose homeostasis
|
J:152695
|
abnormal glycogen homeostasis
|
J:152695
|
decreased circulating glucose level
|
J:152695
|
impaired gluconeogenesis
|
J:152695
|
improved glucose tolerance
|
J:152695
|
increased insulin secretion
|
J:152695
|
increased insulin sensitivity
|
J:152695
|
Atf4tm1Tow/Atf4+ Ptprvtm1Asmi/Ptprv+
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss))
|
decreased circulating glucose level
|
J:152695
|
increased circulating insulin level
|
J:152695
|
Atf4tm1Tow/Atf4tm1Tow
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss))
|
decreased circulating glucose level
|
J:152695
|
impaired gluconeogenesis
|
J:152695
|
improved glucose tolerance
|
J:152695
|
increased circulating insulin level
|
J:152695
|
increased insulin secretion
|
J:152695
|
increased insulin sensitivity
|
J:152695
|
Atf6tm1Hota/Atf6tm1Hota Tg(Ins2-cre)25Mgn/0
(B6.Cg-Atf6tm1Hota Tg(Ins2-cre)25Mgn)
|
increased insulin sensitivity
|
J:213542
|
Atg5tm1Myok/Atg5tm1Myok Tg(Kap-cre)1Isa/0
(involves: 129S/SvEv * C57BL/6 * DBA)
|
increased urine glucose level
|
J:179961
|
Atg12tm1.1Jdth/Atg12tm1.1Jdth Tg(Pomc1-cre)1Gsb/0
(involves: C57BL/6 * FVB/N)
|
impaired glucose tolerance
|
J:232686
|
Atmtm1Pmc/Atm+
(B6.Cg-Atmtm1Pmc)
|
impaired glucose tolerance
|
J:222034
|
insulin resistance
|
J:222034
|
Atmtm1Pmc/Atmtm1Pmc
(B6.Cg-Atmtm1Pmc)
|
impaired glucose tolerance
|
J:222034
|
insulin resistance
|
J:222034
|
Atp1a3tm1b(EUCOMM)Hmgu/Atp1a3+
(C57BL/6N-Atp1a3tm1b(EUCOMM)Hmgu/H)
|
improved glucose tolerance
|
J:211773
|
Atp2a2tm1b(EUCOMM)Hmgu/Atp2a2+
(C57BL/6N-Atp2a2tm1b(EUCOMM)Hmgu/H)
|
increased fasting circulating glucose level
|
J:211773
|
Atp5g2tm2b(EUCOMM)Hmgu/Atp5g2+
(C57BL/6N-Atp5g2tm2b(EUCOMM)Hmgu/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Atp5mdtm1b(EUCOMM)Wtsi/Atp5mdtm1b(EUCOMM)Wtsi
(C57BL/6N-Atp5mdtm1b(EUCOMM)Wtsi/H)
|
decreased circulating glucose level
|
J:211773
|
Atp5otm1.1(KOMP)Vlcg/Atp5o+
(B6N(Cg)-Atp5otm1.1(KOMP)Vlcg/J)
|
improved glucose tolerance
|
J:211773
|
Atp8a2wl/Atp8a2wl
(Not Specified)
|
hypoglycemia
|
J:14851
|
Atp8b1em1(IMPC)Tcp/Atp8b1em1(IMPC)Tcp
(C57BL/6NCrl-Atp8b1em1(IMPC)Tcp/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
improved glucose tolerance
|
J:211773
|
Atpif1em1Jpy/Atpif1em1Jpy
(C57BL/6J-Atpif1em1Jpy)
|
improved glucose tolerance
|
J:313048
|
insulin resistance
|
J:313048
|
Atrtm1b(KOMP)Wtsi/Atr+
(B6N(Cg)-Atrtm1b(KOMP)Wtsi/2J)
|
decreased circulating glucose level
|
J:211773
|
Atriptm1b(KOMP)Wtsi/Atrip+
(B6N(Cg)-Atriptm1b(KOMP)Wtsi/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Atxn2tm1.1Aub/Atxn2tm1.1Aub
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating glucose level
|
J:135320
|
increased circulating insulin level
|
J:135320
|
increased insulin secretion
|
J:135320
|
increased liver glycogen level
|
J:135320
|
AU021092tm1b(KOMP)Wtsi/AU021092tm1b(KOMP)Wtsi
(C57BL/6N-AU021092tm1b(KOMP)Wtsi/Ucd)
|
decreased circulating glucose level
|
J:211773
|
Avpr2tm1Jwe/Y
(involves: 129S1/Sv * 129X1/SvJ * CF-1)
|
hypoglycemia
|
J:66094
|
Azin2Gt(IST12418H6)Tigm/Azin2Gt(IST12418H6)Tigm
(involves: C57BL/6N)
|
decreased circulating insulin level
|
J:204392
|
B2mtm1Jae/B2mtm1Jae Tg(B2m)1Rms/0 Tg(INS-cre)2Rms/0
(involves: 129S2/SvPas * NOD)
|
abnormal glucose homeostasis
|
J:83635
|
B2mtm1Unc/B2mtm1Unc Ciitatm1Ccum/Ciitatm1Ccum
(NOD.Cg-B2mtm1Unc Ciitatm1Ccum)
|
abnormal glucose homeostasis
|
J:107051
|
Baatem1(IMPC)Mbp/Baatem1(IMPC)Mbp
(C57BL/6NCrl-Baatem1(IMPC)Mbp/Mmucd)
|
improved glucose tolerance
|
J:211773
|
Bach1tm1.1(KOMP)Vlcg/Bach1+
(B6N(Cg)-Bach1tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Bach2tm1b(EUCOMM)Wtsi/Bach2tm1b(EUCOMM)Wtsi
(C57BL/6N-Bach2tm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating glucose level
|
J:211773
|
Badtm1Meg/Badtm1Meg
(involves: 129S4/SvJae)
|
decreased circulating insulin level
|
J:133563
|
decreased insulin secretion
|
J:133563
|
increased circulating glucose level
|
J:133563
|
Badtm1Sjk/Badtm1Sjk
(involves: 129X1/SvJ)
|
abnormal circulating glucose level
|
J:133563
|
decreased insulin secretion
|
J:133563
|
increased circulating insulin level
|
J:133563
|
Badtm1Sjk/Badtm1Sjk Tg(Ins2-Mirc13)E4Biat/0
(involves: 129X1/SvJ * C57BL/6N)
|
hyperglycemia
|
J:314874
|
Badtm2Meg/Badtm2Meg
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased insulin secretion
|
J:133563
|
impaired glucose tolerance
|
J:133563
|
Bag3tm1.1Jhl/Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl)
|
decreased circulating insulin level
|
J:144416
|
hypoglycemia
|
J:144416
|
Baiap2l1tm1Zgh/Baiap2l1tm1Zgh
(B6.Cg-Baiap2l1tm1Zgh)
|
impaired glucose tolerance
|
J:238622
|
increased circulating insulin level
|
J:238622
|
increased fasting circulating glucose level
|
J:238622
|
increased hepatic glucose production
|
J:238622
|
insulin resistance
|
J:238622
|
Baz1btm2a(KOMP)Wtsi/Baz1b+
(Not Specified)
|
decreased circulating glucose level
|
J:165965
|
Baz2aem1(IMPC)Tcp/Baz2aem1(IMPC)Tcp
(C57BL/6NCrl-Baz2aem1(IMPC)Tcp/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
Baz2bem1(IMPC)Wtsi/Baz2bem1(IMPC)Wtsi
(C57BL/6N-Baz2bem1(IMPC)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
Bbs4Gt1Nk/Bbs4Gt1Nk
(involves: 129S7/SvEvBrd)
|
increased circulating glucose level
|
J:134093
|
increased circulating insulin level
|
J:134093
|
Bbs5tm1b(EUCOMM)Wtsi/Bbs5tm1b(EUCOMM)Wtsi
(C57BL/6NTac-Bbs5tm1b(EUCOMM)Wtsi/H)
|
impaired glucose tolerance
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Bbs10tm1.2Vmar/Bbs10tm1.2Vmar
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal glucose tolerance
|
J:227230
|
Bbs12tm1.1Vmar/Bbs12tm1.1Vmar
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating glucose level
|
J:189019
|
increased insulin sensitivity
|
J:189019
|
BC048562tm1b(KOMP)Wtsi/BC048562tm1b(KOMP)Wtsi
(C57BL/6N-BC048562tm1b(KOMP)Wtsi/Bay)
|
decreased fasting circulating glucose level
|
J:211773
|
Bcat2tm1.2Clyn/Bcat2tm1.2Clyn
(involves: BALB/cJ * C57BL/6J * C57BL/6N)
|
abnormal glucose homeostasis
|
J:129967
|
decreased circulating glucose level
|
J:129967
|
decreased circulating insulin level
|
J:129967
|
improved glucose tolerance
|
J:129967
|
increased insulin sensitivity
|
J:129967
|
Bckdhatm1a(EUCOMM)Hmgu/Bckdhatm1a(EUCOMM)Hmgu Tg(Ucp1-cre)1Evdr/0
(involves: C57BL/6N * FVB)
|
impaired glucose tolerance
|
J:278806
|
insulin resistance
|
J:278806
|
Bcl2tm1.1Sjk/Bcl2tm1.1Sjk Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6NCrj * SJL)
|
abnormal circulating glucose level
|
J:181308
|
abnormal circulating insulin level
|
J:181308
|
abnormal glucose homeostasis
|
J:181308
|
abnormal glucose tolerance
|
J:181308
|
Bcl6tm1Gdba/Bcl6tm1Gdba Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ)
|
decreased circulating insulin level
|
J:271078
|
decreased fasting circulating glucose level
|
J:271078
|
impaired gluconeogenesis
|
J:271078
|
increased insulin sensitivity
|
J:271078
|
Bcl11btm1.1(KOMP)Vlcg/Bcl11b+
(B6N(Cg)-Bcl11btm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Bcs1ltm1.1Levp/Bcs1ltm1.1Levp
(involves: 129 * 129S6/SvEvTac * C57BL/6)
|
decreased liver glycogen level
|
J:189652
|
Bcs1ltm1.1Levp/Bcs1ltm1.1Levp
(B6.129-Bcs1ltm1.1Levp)
|
decreased circulating glucose level
|
J:273501
|
Bdnftm1Par/Bdnf+
(B6.129S1-Bdnftm1Par)
|
increased circulating insulin level
|
J:59077
|
Bdnftm3Jae/Bdnftm3Jae Tg(Camk2a-cre)93Kln/0
(involves: 129S4/SvJae * CBA/J)
|
increased circulating glucose level
|
J:71969
|
increased circulating insulin level
|
J:71969
|
insulin resistance
|
J:71969
|
Becn2tm1.1Blev/Becn2+
(B6.Cg-Becn2tm1.1Blev)
|
impaired glucose tolerance
|
J:203842
|
increased circulating glucose level
|
J:203842
|
insulin resistance
|
J:203842
|
Betalinc1tm1Suss/Betalinc1tm1Suss
(involves: 129 * C57BL/6)
|
impaired glucose tolerance
|
J:231585
|
increased circulating insulin level
|
J:231585
|
insulin resistance
|
J:231585
|
Bfq1LP/J/Bfq1LP/J
(involves: C57BL/10SnJ * LP/J)
|
decreased circulating insulin level
|
J:42700
|
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd)
|
abnormal glucose homeostasis
|
J:126780
|
decreased circulating insulin level
|
J:126780
|
decreased insulin secretion
|
J:126780
|
impaired glucose tolerance
|
J:126780
|
increased circulating glucose level
|
J:126780
|
insulin resistance
|
J:126780
|
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry Tg(AZIP/F)1Vsn/0
(involves: 129S7/SvEvBrd * FVB/N)
|
increased circulating insulin level
|
J:145998
|
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd)
|
abnormal glucose homeostasis
|
J:126780
|
decreased circulating insulin level
|
J:126780
|
decreased insulin secretion
|
J:126780
|
impaired glucose tolerance
|
J:126780
|
increased circulating glucose level
|
J:126780
|
insulin resistance
|
J:126780
|
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry Tg(AZIP/F)1Vsn/0
(involves: 129S7/SvEvBrd * FVB/N)
|
increased circulating insulin level
|
J:145998
|
Bglu1C57BL/6Slc/Bglu1C3H/HeSlc
(involves: C3H/HeSlc * C57BL/6Slc)
|
hyperglycemia
|
J:62933
|
Bglu1C57BL/6Slc/Bglu1C57BL/6Slc
(involves: C3H/HeSlc * C57BL/6Slc)
|
hyperglycemia
|
J:62933
|
Bglu2C57BL/6Slc/Bglu2C3H/HeSlc
(involves: C3H/HeSlc * C57BL/6Slc)
|
hyperglycemia
|
J:62933
|
Bglu2C57BL/6Slc/Bglu2C57BL/6Slc
(involves: C3H/HeSlc * C57BL/6Slc)
|
hyperglycemia
|
J:62933
|
Bglu3C3H/HeJ/Bglu3C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating glucose level
|
J:108422
|
Bglu3C3H/HeJ/Bglu3C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating glucose level
|
J:108422
|
Bglu4NZB/BlNJ/?
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating glucose level
|
J:138463
|
Bglu5NZW/LacJ/?
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating glucose level
|
J:138463
|
Bglu6NZB/BlNJ/?
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating glucose level
|
J:138463
|
Bglu7NZW/LacJ/?
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating glucose level
|
J:138463
|
Bglu8NZB/BlNJ/Bglu8NZB/BlNJ
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating glucose level
|
J:138463
|
Bglu8NZW/LacJ/Bglu8NZW/LacJ
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating glucose level
|
J:138463
|
Bglu10NZB/BlNJ/?
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating glucose level
|
J:138463
|
Bglu11NZB/BlNJ/Bglu11NZB/BlNJ Bglu9NZB/BlNJ/Bglu9NZB/BlNJ
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating glucose level
|
J:138463
|
Bhlhe40tm1b(KOMP)Wtsi/Bhlhe40tm1b(KOMP)Wtsi
(B6N(Cg)-Bhlhe40tm1b(KOMP)Wtsi/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Bivmtm1b(KOMP)Wtsi/Bivmtm1b(KOMP)Wtsi
(C57BL/6N-Bivmtm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
Blvratm1c(EUCOMM)Hmgu/Blvratm1c(EUCOMM)Hmgu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6J * C57BL/6N)
|
decreased liver glycogen level
|
J:237631
|
impaired glucose tolerance
|
J:237631
|
increased circulating insulin level
|
J:237631
|
increased fasting circulating glucose level
|
J:237631
|
insulin resistance
|
J:237631
|
Bmp4tm1Blh/Bmp4+
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating glucose level
|
J:173500
|
Bmp10tm3b(EUCOMM)Hmgu/Bmp10+
(C57BL/6N-Bmp10tm3b(EUCOMM)Hmgu/Ics)
|
improved glucose tolerance
|
J:211773
|
Bnip3em1(IMPC)Mbp/Bnip3em1(IMPC)Mbp
(C57BL/6N-Bnip3em1(IMPC)Mbp/MbpMmucd)
|
impaired glucose tolerance
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Bola2tm1(KOMP)Wtsi/Bola2tm1(KOMP)Wtsi
(C57BL/6N-Bola2tm1(KOMP)Wtsi/Nju)
|
improved glucose tolerance
|
J:211773
|
Bola3tm1a(EUCOMM)Wtsi/Bola3tm1a(EUCOMM)Wtsi Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * C57BL/6N * FVB/NJ)
|
impaired glucose tolerance
|
J:287367
|
Bpifcem1(IMPC)J/Bpifcem1(IMPC)J
(C57BL/6NJ-Bpifcem1(IMPC)J/Mmjax)
|
impaired glucose tolerance
|
J:211773
|
Braftm1Sva/Braftm1.1Sva Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
hypoglycemia
|
J:121660
|
Braftm1Wds/Braftm1.1Wds Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
hypoglycemia
|
J:121660
|
Brd2Gt(RRT234)Byg/Brd2+
(B6.129P2-Brd2Gt(RRT234)Byg)
|
decreased circulating glucose level
|
J:159964
|
improved glucose tolerance
|
J:159964
|
increased circulating glucagon level
|
J:159964
|
increased circulating insulin level
|
J:159964
|
Brpf3tm1a(EUCOMM)Wtsi/Brpf3+
(B6JTyr;B6N-Brpf3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:175295
|
Brs3tm1Hoh/Brs3tm1Hoh
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal glucose homeostasis
|
J:44242
|
increased circulating insulin level
|
J:44242
|
Brs3tm1Jfb/Brs3tm1Jfb
(B6.129X1-Brs3tm1Jfb)
|
increased circulating insulin level
|
J:134021
|
Bscl2tm1.1Gliu/Bscl2tm1.1Gliu Tg(Fabp4-cre)1Rev/0
(involves: 129 * 129S4/SvJaeSor)
|
increased circulating insulin level
|
J:211072
|
Bscl2tm1.1Lchan/Bscl2tm1.1Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal glucose homeostasis
|
J:183701
|
decreased circulating glucose level
|
J:183701
|
increased circulating glucose level
|
J:183701
|
increased circulating insulin level
|
J:183701
|
insulin resistance
|
J:183701
|
Bscl2tm1.2Gliu/Bscl2tm1.2Gliu
(involves: 129 * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
impaired glucose tolerance
|
J:173404
|
increased circulating glucose level
|
J:173404
|
increased circulating insulin level
|
J:211072,
J:173404
|
insulin resistance
|
J:173404
|
Bscl2tm1b(EUCOMM)Hmgu/Bscl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Bscl2tm1b(EUCOMM)Hmgu/Ics)
|
improved glucose tolerance
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Bscl2tm1Geno/Bscl2tm1Geno
(B6.129P2-Bscl2tm1Geno)
|
hyperglycemia
|
J:200947
|
impaired glucose tolerance
|
J:200947
|
increased circulating glucose level
|
J:200947
|
increased circulating insulin level
|
J:200947
|
insulin resistance
|
J:200947
|
Bsxtm1Tre/Bsxtm1Tre Lepob/Lepob
(B6.Cg-Lepob Bsxtm1Tre)
|
hyperglycemia
|
J:122746
|
increased circulating insulin level
|
J:122746
|
Btbd9tm1b(EUCOMM)Wtsi/Btbd9tm1b(EUCOMM)Wtsi
(C57BL/6N-Btbd9tm1b(EUCOMM)Wtsi/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Btg2tm1b(KOMP)Mbp/Btg2tm1b(KOMP)Mbp
(B6N(Cg)-Btg2tm1b(KOMP)Mbp/2J)
|
increased fasting circulating glucose level
|
J:211773
|
Bub1btm1Jvd/Bub1btm1Jvd
(involves: 129S6/SvEvTac * C57BL/6 * FVB)
|
hypoglycemia
|
J:234643
|
improved glucose tolerance
|
J:234643
|
increased insulin sensitivity
|
J:234643
|
Bub1btm1Jvd/Bub1btm1Jvd Mad2l1bptm1.1Itl/Mad2l1bptm1.1Itl Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * FVB)
|
hypoglycemia
|
J:234643
|
improved glucose tolerance
|
J:234643
|
increased insulin sensitivity
|
J:234643
|
Bud23em2(IMPC)H/Bud23+
(C57BL/6N-Bud23em2(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
Bvestm1.1(KOMP)Vlcg/Bvestm1.1(KOMP)Vlcg
(C57BL/6N-Bvestm1.1(KOMP)Vlcg/Ucd)
|
improved glucose tolerance
|
J:211773
|
Bwt1HRS/J/Bwt1HRS/J Find1C57BLKS/J/Find1C57BLKS/J
(involves: C57BLKS/J * HRS/J)
|
increased circulating glucose level
|
J:100832
|
Bzw2tm1b(KOMP)Mbp/Bzw2tm1b(KOMP)Mbp
(B6N(Cg)-Bzw2tm1b(KOMP)Mbp/J)
|
decreased circulating glucose level
|
J:211773
|
C1qatm1b(EUCOMM)Wtsi/C1qatm1b(EUCOMM)Wtsi
(B6N(Cg)-C1qatm1b(EUCOMM)Wtsi/3J)
|
decreased circulating glucose level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
C1qtnf1tm1Lex/C1qtnf1tm1Lex
(B6.129S5-C1qtnf1tm1Lex)
|
impaired glucose tolerance
|
J:241403
|
increased circulating insulin level
|
J:241403
|
insulin resistance
|
J:241403
|
C1qtnf5tm1(KOMP)Vlcg/C1qtnf5tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased circulating insulin level
|
J:237401
|
decreased fasting circulating glucose level
|
J:237401
|
impaired gluconeogenesis
|
J:237401
|
improved glucose tolerance
|
J:237401
|
increased insulin secretion
|
J:237401
|
increased insulin sensitivity
|
J:237401
|
C1qtnf5tm1.1(KOMP)Vlcg/C1qtnf5+
(B6N(Cg)-C1qtnf5tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
C1qtnf7tm1(KOMP)Vlcg/C1qtnf7tm1(KOMP)Vlcg
(C57BL/6N-C1qtnf7tm1(KOMP)Vlcg)
|
decreased circulating glucose level
|
J:244352
|
improved glucose tolerance
|
J:244352
|
C1qtnf9tm1(KOMP)Vlcg/C1qtnf9tm1(KOMP)Vlcg
(C57BL/6-C1qtnf9tm1(KOMP)Vlcg)
|
increased circulating insulin level
|
J:212299
|
increased insulin secretion
|
J:212299
|
insulin resistance
|
J:212299
|
C2cd5Gt(IST12020E4)Tigm/C2cd5Gt(IST12020E4)Tigm
(C57BL/6N-C2cd5Gt(IST12020E4)Tigm)
|
abnormal glucose homeostasis
|
J:284780
|
decreased hepatic glucose production
|
J:284780
|
impaired glucose tolerance
|
J:284780
|
increased fasting circulating glucose level
|
J:284780
|
insulin resistance
|
J:284780
|
C3tm1Hrc/C3tm1Hrc
(involves: 129/Sv * C57BL/6)
|
abnormal glucose homeostasis
|
J:60633,
J:58966
|
decreased circulating glucose level
|
J:60633,
J:58966
|
decreased circulating insulin level
|
J:60633
|
C3tm1Hrc/C3tm1Hrc
(involves: 129)
|
decreased circulating insulin level
|
J:87945
|
C3tm1Hrc/C3tm1Hrc Lepob/Lepob
(involves: 129 * C57BL/6)
|
abnormal glucose homeostasis
|
J:80546
|
decreased circulating insulin level
|
J:80546
|
C5ar2tm1Gdy/C5ar2tm1Gdy
(involves: 129 * C57BL/6)
|
abnormal glucose homeostasis
|
J:123294
|
increased circulating insulin level
|
J:123294
|
cab/cab
(STOCK Cacna1smdg)
|
abnormal glucose homeostasis
|
J:7797
|
decreased glycogen level
|
J:6195,
J:7797
|
hypoglycemia
|
J:7797
|
Cabp5tm1b(KOMP)Wtsi/Cabp5tm1b(KOMP)Wtsi
(C57BL/6N-Cabp5tm1b(KOMP)Wtsi/BayMmucd)
|
impaired glucose tolerance
|
J:211773
|
Cacna1atg-rol/Cacna1a+
(involves: C3Hf/Nga * C57BL/6 * SIII)
|
abnormal glucose homeostasis
|
J:3611
|
Cacna1atg-rol/Cacna1atg-rol
(involves: C3Hf/Nga * C57BL/6 * SIII)
|
abnormal glucose homeostasis
|
J:3611
|
Cacna1btm1b(KOMP)Wtsi/Cacna1btm1b(KOMP)Wtsi
(C57BL/6N-Cacna1btm1b(KOMP)Wtsi/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Cacna1btm1Ksw/Cacna1btm1Ksw
(involves: C57BL/6 * CBA)
|
decreased circulating glucagon level
|
J:105212
|
decreased circulating insulin level
|
J:105212
|
improved glucose tolerance
|
J:105212
|
Cacna1ctm3Hfm/Cacna1ctm3Hfm Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
decreased circulating insulin level
|
J:84919
|
decreased insulin secretion
|
J:84919
|
impaired glucose tolerance
|
J:84919
|
increased circulating glucose level
|
J:84919
|
Cacna1dtm1Hssh/Cacna1dtm1Hssh
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating insulin level
|
J:72316
|
decreased insulin secretion
|
J:72316
|
impaired glucose tolerance
|
J:72316
|
increased insulin sensitivity
|
J:72316
|
Cacna1etm1.1Tsch/Cacna1etm1.1Tsch
(involves: C57BL/6)
|
abnormal glucagon secretion
|
J:95377
|
decreased circulating glucagon level
|
J:95377
|
decreased insulin secretion
|
J:95377
|
impaired glucose tolerance
|
J:95377
|
increased circulating glucose level
|
J:95377
|
Cacna1etm1.1Tsch/Cacna1etm1.1Tsch
(involves: BALB/cJ * C57BL/6)
|
decreased glucagon secretion
|
J:101873
|
decreased insulin secretion
|
J:95636
|
hyperglycemia
|
J:95636
|
impaired glucose tolerance
|
J:95636
|
increased circulating glucose level
|
J:101873
|
Cacna1ftm1.1(KOMP)Vlcg/Cacna1ftm1.1(KOMP)Vlcg
(C57BL/6N-Cacna1ftm1.1(KOMP)Vlcg/Ucd)
|
increased circulating insulin level
|
J:211773
|
Cacna1stm1.1(KOMP)Vlcg/Cacna1s+
(B6N(Cg)-Cacna1stm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Cacna2d1em1(IMPC)Mbp/Cacna2d1em1(IMPC)Mbp
(C57BL/6N-Cacna2d1em1(IMPC)Mbp/MbpMmucd)
|
impaired glucose tolerance
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cacna2d3tm1b(KOMP)Wtsi/Cacna2d3+
(B6N(Cg)-Cacna2d3tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
Cacnb2tm1.1(KOMP)Vlcg/Cacnb2tm1.1(KOMP)Vlcg
(C57BL/6N-Cacnb2tm1.1(KOMP)Vlcg/Tcp)
|
impaired glucose tolerance
|
J:211773
|
Cadps2tm1Bros/Cadps2tm1Bros
(Not Specified)
|
decreased insulin secretion
|
J:131014
|
impaired glucose tolerance
|
J:131014
|
increased glucagon secretion
|
J:131014
|
increased insulin sensitivity
|
J:131014
|
Cadpstm1Bros/Cadps+ Cadps2tm1Bros/Cadps2tm1Bros
(Not Specified)
|
abnormal glucose homeostasis
|
J:131014
|
decreased insulin secretion
|
J:131014
|
impaired glucose tolerance
|
J:131014
|
increased glucagon secretion
|
J:131014
|
increased insulin sensitivity
|
J:131014
|
Calrtm1Mlk/Calrtm1Mlk
(involves: 129S4/SvJae * C57BL/6J)
|
increased cardiac muscle glycogen level
|
J:119647
|
Camk1tm2b(EUCOMM)Hmgu/Camk1tm2b(EUCOMM)Hmgu
(C57BL/6N-Camk1tm2b(EUCOMM)Hmgu/Bay)
|
decreased fasting circulating glucose level
|
J:211773
|
Camk2btm1b(EUCOMM)Hmgu/Camk2b+
(C57BL/6N-Camk2btm1b(EUCOMM)Hmgu/Ieg)
|
improved glucose tolerance
|
J:211773
|
Camk4em1(IMPC)Ccpcz/Camk4em1(IMPC)Ccpcz
(C57BL/6N-Camk4em1(IMPC)Ccpcz/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Camkk2tm1.1Arm/Camkk2tm1.1Arm
(involves: C57BL/6)
|
abnormal glucose homeostasis
|
J:136219
|
improved glucose tolerance
|
J:136219
|
Camsap3tm1a(EUCOMM)Wtsi/Camsap3tm1a(EUCOMM)Wtsi
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
Cand1em1(IMPC)Mbp/Cand1+
(C57BL/6NCrl-Cand1em1(IMPC)Mbp/Mmucd)
|
increased fasting circulating glucose level
|
J:211773
|
Candy/Candy
(involves: C3H/HeH * C57BL/6J)
|
hyperglycemia
|
J:169366
|
increased urine glucose level
|
J:169366
|
Candy2/Candy2
(involves: C3H/HeH * C57BL/6J)
|
hyperglycemia
|
J:169366
|
increased urine glucose level
|
J:169366
|
Candy3/Candy3
(involves: C3H/HeH * C57BL/6J)
|
hyperglycemia
|
J:169366
|
increased urine glucose level
|
J:169366
|
Candy4/Candy4
(involves: C3H/HeH * C57BL/6J)
|
hyperglycemia
|
J:169366
|
increased urine glucose level
|
J:169366
|
Candy5/Candy5
(involves: C3H/HeH * C57BL/6J)
|
hyperglycemia
|
J:163957
|
Capn11tm1b(EUCOMM)Wtsi/Capn11tm1b(EUCOMM)Wtsi
(C57BL/6N-Capn11tm1b(EUCOMM)Wtsi/Wtsi)
|
impaired glucose tolerance
|
J:211773
|
Capn12tm1b(EUCOMM)Hmgu/Capn12tm1b(EUCOMM)Hmgu
(C57BL/6N-Capn12tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating glucose level
|
J:211773
|
Car5atm1Sly/Car5atm1Sly Car5btm1Sly/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating glucose level
|
J:196135
|
Car5atm1Sly/Car5atm1Sly Car5btm1Sly/Car5btm1Sly
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating glucose level
|
J:196135
|
Carmil2tm1b(KOMP)Mbp/Carmil2tm1b(KOMP)Mbp
(C57BL/6N-Carmil2tm1b(KOMP)Mbp/Orl)
|
increased circulating glucose level
|
J:211773
|
Cartpttm1Amgn/Cartpttm1Amgn
(involves: 129X1/SvJ * Black Swiss)
|
decreased insulin secretion
|
J:103911
|
impaired glucose tolerance
|
J:103911
|
increased circulating insulin level
|
J:103911
|
Casp4tm1b(KOMP)Wtsi/Casp4tm1b(KOMP)Wtsi
(C57BL/6N-Casp4tm1b(KOMP)Wtsi/Ucd)
|
increased circulating glucose level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Casttm1.1(KOMP)Vlcg/Casttm1.1(KOMP)Vlcg
(B6N(Cg)-Casttm1.1(KOMP)Vlcg/2J)
|
decreased fasting circulating glucose level
|
J:211773
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
increased circulating insulin level
|
J:84260
|
insulin resistance
|
J:84260
|
Cav1tm1Mls/Cav1tm1Mls
(FVB.Cg-Cav1tm1Mls)
|
abnormal glucose homeostasis
|
J:182288
|
decreased liver glycogen level
|
J:182288
|
enhanced gluconeogenesis
|
J:182288
|
hyperglycemia
|
J:182288
|
increased circulating insulin level
|
J:182288
|
increased liver glycogen level
|
J:182288
|
insulin resistance
|
J:182288
|
Cav1tm1Pesch/Cav1tm1Pesch Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(FVB.Cg-Cav1tm1Pesch Speer6-ps1Tg(Alb-cre)21Mgn)
|
decreased circulating glucose level
|
J:182288
|
Cavin1tm1Pfp/Cavin1tm1Pfp
(involves: 129S6/SvEvTac * C57BL/6)
|
impaired glucose tolerance
|
J:143425
|
increased circulating insulin level
|
J:143425
|
insulin resistance
|
J:143425
|
Cbltm1Ddlb/Cbl+
(involves: 129S1/Sv * C57BL/6)
|
improved glucose tolerance
|
J:121012
|
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6)
|
abnormal glucose homeostasis
|
J:94416
|
decreased circulating insulin level
|
J:94416
|
improved glucose tolerance
|
J:94416
|
increased insulin sensitivity
|
J:94416
|
Cbltm1Ddlb/Cbltm2Wlan
(involves: 129S1/Sv * C57BL/6)
|
decreased circulating insulin level
|
J:121012
|
improved glucose tolerance
|
J:121012
|
increased insulin sensitivity
|
J:121012
|
Cbliftm1a(KOMP)Wtsi/Cbliftm1a(KOMP)Wtsi
(C57BL/6N-Cbliftm1a(KOMP)Wtsi)
|
decreased circulating glucose level
|
J:236022
|
Cbx5tm1a(EUCOMM)Wtsi/Cbx5tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx5tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
Cbx6tm1a(EUCOMM)Wtsi/Cbx6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx6tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Ccar2tm1Dac/Ccar2tm1Dac
(involves: 129 * C57BL/6J)
|
impaired glucose tolerance
|
J:228688
|
increased circulating insulin level
|
J:228688
|
increased hepatic glucose production
|
J:228688
|
insulin resistance
|
J:228688
|
Ccar2tm1Dac/Ccar2tm1Dac Lepob/Lepob
(involves: 129 * C57BL/6J)
|
impaired glucose tolerance
|
J:228688
|
Ccdc3tm1Ish/Ccdc3tm1Ish
(involves: C57BL/6J)
|
abnormal glucose homeostasis
|
J:220560
|
increased circulating glucose level
|
J:220560
|
increased insulin sensitivity
|
J:220560
|
Ccdc50tm1b(EUCOMM)Hmgu/Ccdc50tm1b(EUCOMM)Hmgu
(C57BL/6N-Ccdc50tm1b(EUCOMM)Hmgu/H)
|
impaired glucose tolerance
|
J:211773
|
Ccdc51em1(IMPC)J/Ccdc51em1(IMPC)J
(C57BL/6NJ-Ccdc51em1(IMPC)J/Mmjax)
|
increased fasting circulating glucose level
|
J:211773
|
Ccdc57tm1a(EUCOMM)Wtsi/Ccdc57+
(B6JTyr;B6N-Ccdc57tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:175295
|
Ccdc80tm1Ftrm/Ccdc80tm1Ftrm
(C57BL/6-Ccdc80tm1Ftrm)
|
decreased circulating insulin level
|
J:189183
|
impaired glucose tolerance
|
J:189183
|
increased circulating glucose level
|
J:189183
|
increased insulin secretion
|
J:189183
|
Ccdc88bem1(IMPC)Tcp/Ccdc88bem1(IMPC)Tcp
(C57BL/6NCrl-Ccdc88bem1(IMPC)Tcp/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
Ccdc120tm1.1(KOMP)Vlcg/Y
(B6N(Cg)-Ccdc120tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Ccdc120tm1.1(KOMP)Vlcg/Ccdc120tm1.1(KOMP)Vlcg
(B6N(Cg)-Ccdc120tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol/J)
|
abnormal gluconeogenesis
|
J:110277
|
abnormal glucose homeostasis
|
J:126512
|
decreased circulating insulin level
|
J:110277
|
impaired glucose tolerance
|
J:126512
|
improved glucose tolerance
|
J:110277
|
increased circulating glucose level
|
J:126512
|
increased circulating insulin level
|
J:126512
|
increased insulin sensitivity
|
J:110277
|
Ccl25em1(IMPC)H/Ccl25em1(IMPC)H
(C57BL/6N-Ccl25em1(IMPC)H/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Ccl26tm1.1(KOMP)Vlcg/Ccl26tm1.1(KOMP)Vlcg
(B6N(Cg)-Ccl26tm1.1(KOMP)Vlcg/J)
|
improved glucose tolerance
|
J:211773
|
Ccnd2tm1b(KOMP)Mbp/Ccnd2tm1b(KOMP)Mbp
(C57BL/6N-Ccnd2tm1b(KOMP)Mbp/H)
|
impaired glucose tolerance
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Ccr2tm1.1(CCR2)Rodb/Ccr2tm1.1(CCR2)Rodb
(involves: C57BL/6)
|
abnormal glucose homeostasis
|
J:203000
|
Ccr5tm1Kuz/Ccr5tm1Kuz
(B6.129P2-Ccr5tm1Kuz/J)
|
decreased skeletal muscle glycogen level
|
J:264446
|
Cd5ltm1b(KOMP)Mbp/Cd5ltm1b(KOMP)Mbp
(C57BL/6N-Cd5ltm1b(KOMP)Mbp/H)
|
decreased circulating glucose level
|
J:211773
|
Cd33tm1.1(KOMP)Vlcg/Cd33tm1.1(KOMP)Vlcg
(B6N(Cg)-Cd33tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Cd36em1(IMPC)Mbp/Cd36em1(IMPC)Mbp
(C57BL/6N-Cd36em1(IMPC)Mbp/MbpMmucd)
|
decreased fasting circulating glucose level
|
J:211773
|
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle glycogen level
|
J:83611
|
decreased fasting circulating glucose level
|
J:56081
|
Cd36tm1Mfe/Cd36tm1Mfe
(B6.129S1-Cd36tm1Mfe)
|
abnormal gluconeogenesis
|
J:87372
|
abnormal glucose homeostasis
|
J:87372
|
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv)
|
decreased circulating glucose level
|
J:220343
|
decreased skeletal muscle glycogen level
|
J:220343
|
Cd36tm2.1Mfe/Cd36tm2.1Mfe A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(B6.Cg-Cd36tm2.1Mfe A1cfTg(Myh6-cre/Esr1*)1Jmk)
|
abnormal glucose homeostasis
|
J:225392
|
Cd38tm1Lnd/Cd38tm1Lnd
(B6.129P2-Cd38tm1Lnd)
|
insulin resistance
|
J:116576
|
Cd38tm1Okam/Cd38tm1Okam
(involves: C57BL/6 * CBA)
|
decreased circulating insulin level
|
J:52933
|
impaired glucose tolerance
|
J:52933
|
Cd248tm1.1(KOMP)Vlcg/Cd248tm1.1(KOMP)Vlcg
(C57BL/6N-Cd248tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating insulin level
|
J:211773
|
Cd300etm1.1(KOMP)Vlcg/Cd300etm1.1(KOMP)Vlcg
(C57BL/6N-Cd300etm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating glucose level
|
J:211773
|
Cdc20tm1.1(KOMP)Vlcg/Cdc20+
(B6N(Cg)-Cdc20tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
improved glucose tolerance
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cdc34tm1.1(KOMP)Mbp/Cdc34+
(B6N(Cg)-Cdc34tm1.1(KOMP)Mbp/J)
|
increased fasting circulating glucose level
|
J:211773
|
Cdh1tm2Kem/Cdh1tm2Kem Tg(Ins2-cre)23Herr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
decreased insulin secretion
|
J:196410
|
impaired glucose tolerance
|
J:196410
|
Cdh23tm2b(EUCOMM)Wtsi/Cdh23tm2b(EUCOMM)Wtsi
(C57BL/6N-Cdh23tm2b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Cdk4tm1Bbd/Cdk4tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
decreased circulating insulin level
|
J:54534
|
hyperglycemia
|
J:54534
|
increased urine glucose level
|
J:54534
|
Cdk4tm1Kiyo/Cdk4tm1Kiyo
(involves: 129S1/Sv * C57BL/6)
|
increased urine glucose level
|
J:57854
|
Cdk4wnch/Cdk4wnch
(C57BL/6JAnu-Cdk4wnch)
|
abnormal glucose homeostasis
|
J:104190
|
Cdk5rap1tm1.2Tomik/Cdk5rap1tm1.2Tomik
(B6J.Cg-Cdk5rap1tm1.2Tomik)
|
decreased circulating glucose level
|
J:220703
|
Cdk5rap3tm1b(EUCOMM)Hmgu/Cdk5rap3+
(C57BL/6N-Cdk5rap3tm1b(EUCOMM)Hmgu/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Cdk5rap3tm1c(EUCOMM)Hmgu/Cdk5rap3tm1c(EUCOMM)Hmgu Tg(Foxa3-cre)1Khk/0
(involves: 129S4/SvJaeSor * C57BL/6N * DBA)
|
decreased fasting circulating glucose level
|
J:272566
|
hypoglycemia
|
J:272566
|
Cdk8tm1a(EUCOMM)Hmgu/Cdk8tm1a(EUCOMM)Hmgu Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
decreased circulating insulin level
|
J:281075
|
improved glucose tolerance
|
J:281075
|
increased circulating glucose level
|
J:281075
|
increased insulin secretion
|
J:281075
|
Cdk8tm1a(EUCOMM)Hmgu/Cdk8tm1a(EUCOMM)Hmgu Tg(Pdx1-cre)6Tuv/0
(involves: C57BL/6N * FVB/N)
|
improved glucose tolerance
|
J:281075
|
increased insulin secretion
|
J:281075
|
Cdkal1Gt(6062)Tgen/Cdkal1Gt(6062)Tgen
(involves: C57BL/6 * C57BL/6J * CBA/JNCrj)
|
abnormal glucose homeostasis
|
J:195460
|
decreased circulating glucose level
|
J:195460
|
decreased circulating insulin level
|
J:195460
|
decreased insulin secretion
|
J:195460
|
Cdkal1tm1.1Tomik/Cdkal1tm1.1Tomik Tg(Ins2-cre)25Mgn/0
(B6.Cg-Cdkal1tm1.1Tomik Tg(Ins2-cre)25Mgn)
|
abnormal insulin secretion
|
J:178248
|
decreased insulin secretion
|
J:178248
|
impaired glucose tolerance
|
J:178248
|
increased circulating glucose level
|
J:178248
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * 129S2/SvPas)
|
impaired glucose tolerance
|
J:118516
|
insulin resistance
|
J:118516
|
Cdkn1btm1Kin/Cdkn1b+ Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating glucose level
|
J:96047
|
increased circulating insulin level
|
J:96047
|
Cdkn1btm1Kin/Cdkn1b+ Leprdb/Leprdb
(involves: C57BL/6J * C57BLKS/J)
|
hyperglycemia
|
J:96047
|
increased circulating insulin level
|
J:96047
|
Cdkn1btm1Kin/Cdkn1btm1Kin Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating glucose level
|
J:96047
|
increased circulating insulin level
|
J:96047
|
Cdkn1btm1Kin/Cdkn1btm1Kin Leprdb/Leprdb
(involves: C57BL/6J * C57BLKS/J)
|
increased circulating insulin level
|
J:96047
|
Cdo1tm1.1Mhst/Cdo1tm1.1Mhst
(involves: C57BL/6)
|
decreased circulating glucose level
|
J:182195
|
Ceacam2tm1Snaj/Ceacam2tm1Snaj
(involves: 129S4/SvJae * C57BL/6)
|
abnormal glucose homeostasis
|
J:181979
|
abnormal glycogen homeostasis
|
J:181979
|
impaired glucose tolerance
|
J:181979
|
increased circulating insulin level
|
J:181979
|
increased insulin secretion
|
J:181979
|
insulin resistance
|
J:181979
|
Cebpatm1Gjd/Cebpatm1Gjd
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal gluconeogenesis
|
J:28320
|
abnormal glucose homeostasis
|
J:28320
|
abnormal glycogen homeostasis
|
J:28320
|
decreased liver glycogen level
|
J:28320
|
hypoglycemia
|
J:28320
|
Cebpatm1Gonz/Cebpatm1Gonz Lepob/Lepob Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased circulating insulin level
|
J:93579
|
impaired glucose tolerance
|
J:93579
|
increased circulating glucose level
|
J:93579
|
increased liver glycogen level
|
J:93579
|
insulin resistance
|
J:93579
|
Cebpatm1Kgx/Cebpatm1Kgx
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal glucose homeostasis
|
J:35795
|
decreased liver glycogen level
|
J:35795
|
hypoglycemia
|
J:35795
|
Cebpatm1Timc/Cebpatm1Timc
(Not Specified)
|
decreased circulating glucose level
|
J:163725
|
Cebpatm6Nerl/Cebpatm6Nerl
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating insulin level
|
J:120098
|
decreased liver glycogen level
|
J:120098
|
impaired glucose tolerance
|
J:120098
|
increased circulating glucose level
|
J:120098
|
Cebpatm8.1Nerl/Cebpatm8.1Nerl
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
hypoglycemia
|
J:136134
|
Cebpbtm1.1Maka/Cebpbtm1.1Maka Ins2Akita/Ins2Akita Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NSlc * CBA/J)
|
decreased circulating insulin level
|
J:156725
|
decreased insulin secretion
|
J:156725
|
increased circulating glucose level
|
J:156725
|
Cebpbtm1.1Maka/Cebpbtm1.1Maka Leprdb/Leprdb Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BLKS/J * CBA/J)
|
hyperglycemia
|
J:156725
|
increased circulating insulin level
|
J:156725
|
Cebpbtm1.1Maka/Cebpbtm1.1Maka Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
increased insulin secretion
|
J:156725
|
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1)
|
abnormal gluconeogenesis
|
J:52286
|
abnormal glucose homeostasis
|
J:62132,
J:52286
|
decreased circulating insulin level
|
J:62132
|
decreased glycogen catabolism rate
|
J:52286
|
hypoglycemia
|
J:62132,
J:52286
|
increased insulin sensitivity
|
J:62132
|
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * C57BL/6 * MF1)
|
abnormal gluconeogenesis
|
J:49673
|
abnormal glucose homeostasis
|
J:49673
|
hypoglycemia
|
J:49673
|
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * C57BL/6)
|
increased circulating glucose level
|
J:117502
|
Celtm1Dyh/Celtm1Dyh Pnliptm1Dyh/Pnliptm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating insulin level
|
J:124658
|
insulin resistance
|
J:124658
|
Celf4tm1a(EUCOMM)Wtsi/Celf4+
(C57BL/6N-Celf4tm1a(EUCOMM)Wtsi/Wtsi)
|
impaired glucose tolerance
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Cenpetm1b(EUCOMM)Hmgu/Cenpe+
(C57BL/6N-Cenpetm1b(EUCOMM)Hmgu/Cnrm)
|
increased fasting circulating glucose level
|
J:211773
|
Cenpjtm1a(EUCOMM)Wtsi/Cenpjtm1a(EUCOMM)Wtsi
(B6Brd;B6N-Tyrc-Brd Cenpjtm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal glucose tolerance
|
J:194085
|
Cenpotm1b(KOMP)Mbp/Cenpo+
(B6N(Cg)-Cenpotm1b(KOMP)Mbp/J)
|
decreased circulating glucose level
|
J:211773
|
Cep19tm2.1Jmgi/Cep19tm2.1Jmgi
(involves: C57BL/6NTac)
|
impaired glucose tolerance
|
J:206667
|
increased circulating glucose level
|
J:206667
|
insulin resistance
|
J:206667
|
Cep57l1tm1b(KOMP)Wtsi/Cep57l1+
(B6N(Cg)-Cep57l1tm1b(KOMP)Wtsi/2J)
|
increased fasting circulating glucose level
|
J:211773
|
Cept1tm1.1Sem/Cept1tm1.1Sem Tg(ACTA1-cre)79Jme/0
(involves: C57BL/6J * SJL)
|
decreased circulating glucose level
|
J:249456
|
improved glucose tolerance
|
J:249456
|
increased insulin sensitivity
|
J:249456
|
Cers6tm1.1Arte/Cers6tm1.1Arte
(involves: BALB/cJ * C57BL/6N)
|
decreased circulating insulin level
|
J:215519
|
improved glucose tolerance
|
J:215519
|
Cers6tm1Arte/Cers6tm1Arte Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6N * FVB/N)
|
improved glucose tolerance
|
J:215519
|
Ces1dtm1Rile/Ces1dtm1Rile
(involves: 129S6/SvEvTac)
|
decreased circulating glucose level
|
J:158743
|
improved glucose tolerance
|
J:158743
|
increased insulin sensitivity
|
J:158743
|
Ces1gtm1Reli/Ces1gtm1Reli
(involves: 129S/SvEv * C57BL/6)
|
abnormal glucose homeostasis
|
J:262803
|
decreased fasting circulating glucose level
|
J:262803
|
increased circulating insulin level
|
J:262803
|
increased insulin sensitivity
|
J:262803
|
insulin resistance
|
J:262803
|
Cfitm1b(EUCOMM)Hmgu/Cfitm1b(EUCOMM)Hmgu
(C57BL/6N-Cfitm1b(EUCOMM)Hmgu/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Chd8em1(IMPC)Mbp/Chd8+
(C57BL/6N-Chd8em1(IMPC)Mbp/MbpMmucd)
|
impaired glucose tolerance
|
J:211773
|
Chgbtm1Ribo/Chgbtm1Ribo
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased insulin secretion
|
J:157614
|
impaired glucose tolerance
|
J:157614
|
Chn1em1(IMPC)J/Chn1+
(C57BL/6NJ-Chn1em1(IMPC)J/J)
|
decreased circulating glucose level
|
J:211773
|
Chn1tm1.1(KOMP)Vlcg/Chn1tm1.1(KOMP)Vlcg
(B6N(Cg)-Chn1tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Chp2tm1b(KOMP)Mbp/Chp2+
(B6N(Cg)-Chp2tm1b(KOMP)Mbp/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Chrdl1em1(IMPC)H/Chrdl1em1(IMPC)H
(C57BL/6NTac-Chrdl1em1(IMPC)H/H)
|
increased fasting circulating glucose level
|
J:211773
|
Chrm3tm1Jwe/Chrm3+
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating insulin level
|
J:91888
|
decreased insulin secretion
|
J:91888
|
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal glucose homeostasis
|
J:67919
|
decreased circulating glucagon level
|
J:91888
|
decreased circulating glucose level
|
J:91888
|
decreased circulating insulin level
|
J:91888,
J:67919
|
decreased glucagon secretion
|
J:91888
|
decreased insulin secretion
|
J:91888
|
improved glucose tolerance
|
J:91888
|
increased insulin sensitivity
|
J:67919
|
Chrm3tm2.1Jwe/Chrm3tm2.1Jwe Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N)
|
decreased circulating glucose level
|
J:158245
|
Chrm3tm2Jwe/Chrm3tm2Jwe Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
decreased insulin secretion
|
J:129643
|
impaired glucose tolerance
|
J:129643
|
Cibar1tm1b(KOMP)Wtsi/Cibar1tm1b(KOMP)Wtsi
(C57BL/6N-Cibar1tm1b(KOMP)Wtsi/Wtsi)
|
improved glucose tolerance
|
J:211773
|
Cideatm1Pli/Cideatm1Pli
(involves: 129X1/SvJ)
|
abnormal circulating glucose level
|
J:85229
|
abnormal glucose homeostasis
|
J:85229
|
Cidebtm1Pli/Cidebtm1Pli
(Not Specified)
|
increased insulin sensitivity
|
J:126556
|
Cidectm1.1Gonz/Cidectm1.2Gonz Tg(Fabp4-cre)#Abel/?
(B6N.Cg-Cidectm1.1Gonz/Cidectm1.2Gonz Tg(Fabp4-cre)#Abel)
|
increased circulating insulin level
|
J:226899
|
insulin resistance
|
J:226899
|
Cidectm1b(EUCOMM)Wtsi/Cidectm1b(EUCOMM)Wtsi
(C57BL/6N-Cidectm1b(EUCOMM)Wtsi/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Cidectm1Maka/Cidectm1Maka
(B6.129P2-Cidectm1Maka)
|
decreased circulating glucose level
|
J:140863
|
improved glucose tolerance
|
J:140863
|
Cidectm1Pli/Cidectm1Pli
(Not Specified)
|
improved glucose tolerance
|
J:140122
|
increased insulin sensitivity
|
J:140122
|
Cidectm1Pli/Cidectm1Pli Lepob/Lepob
(involves: C57BL/10J)
|
improved glucose tolerance
|
J:140122
|
increased insulin sensitivity
|
J:140122
|
Ciitatm1Ccum/Ciitatm1Ccum
(NOD.129S2(B6)-Ciitatm1Ccum)
|
abnormal circulating glucose level
|
J:106081
|
Cinptm1.1(KOMP)Vlcg/Cinp+
(B6N(Cg)-Cinptm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Cisd2tm1a(EUCOMM)Wtsi/Cisd2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cisd2tm1a(EUCOMM)Wtsi/H)
|
abnormal glucose homeostasis
|
J:165965
|
Cisd2tm1Tfts/Cisd2tm1Tfts
(B6.129S7-Cisd2tm1Tfts)
|
abnormal glucose homeostasis
|
J:148467
|
decreased insulin secretion
|
J:148467
|
impaired glucose tolerance
|
J:148467
|
increased insulin sensitivity
|
J:148467
|
Ckmtm1Bew/Ckmtm1Bew
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased glycogen catabolism rate
|
J:76699
|
increased skeletal muscle glycogen level
|
J:76699
|
Clcn3tm1Lamb/Clcn3tm1Lamb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased circulating glucose level
|
J:80901
|
Clcn5tm1Gug/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased urine glucose level
|
J:66560
|
Clcn5tm1Tjj/Y
(involves: 129)
|
increased urine glucose level
|
J:160701
|
Clcn5tm2.1Tjj/Y
(involves: 129P2/OlaHsd * 129X1/SvJ * BALB/cJ * C57BL/6)
|
increased urine glucose level
|
J:160701
|
Clcnkbem1(IMPC)Mbp/Clcnkbem1(IMPC)Mbp
(C57BL/6NCrl-Clcnkbem1(IMPC)Mbp/MbpMmucd)
|
improved glucose tolerance
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cldn12tm1.1(KOMP)Vlcg/Cldn12tm1.1(KOMP)Vlcg
(B6J.B6N-Cldn12tm1.1(KOMP)Vlcg)
|
decreased fasting circulating glucose level
|
J:279934
|
increased circulating glucose level
|
J:279934
|
Cldn13em1(IMPC)J/Cldn13em1(IMPC)J
(C57BL/6NJ-Cldn13em1(IMPC)J/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Cldn13tm1.1(KOMP)Vlcg/Cldn13tm1.1(KOMP)Vlcg
(B6N(Cg)-Cldn13tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Cldnd2tm1b(EUCOMM)Hmgu/Cldnd2tm1b(EUCOMM)Hmgu
(C57BL/6N-Cldnd2tm1b(EUCOMM)Hmgu/Orl)
|
increased fasting circulating glucose level
|
J:211773
|
Clec16aem1(IMPC)J/Clec16a+
(C57BL/6NJ-Clec16aem1(IMPC)J/Mmjax)
|
improved glucose tolerance
|
J:211773
|
Clec16atm1.1Hhak/Clec16atm1.1Hhak Tg(Pdx1-cre)1Herr/0
(involves: C57BL/6 * C57BL/6J * CBA/J * SJL)
|
decreased insulin secretion
|
J:214528
|
hyperglycemia
|
J:214528
|
impaired glucose tolerance
|
J:214528
|
Clic5jbg/Clic5jbg
(involves: C3H/HeJ * C57BL/6)
|
decreased circulating glucose level
|
J:160186
|
decreased circulating insulin level
|
J:160186
|
increased circulating glucagon level
|
J:160186
|
Clockm1Jt/Clockm1Jt
(C57BL/6-Clockm1Jt)
|
increased circulating glucose level
|
J:98343
|
Clockm1Jt/Clockm1Jt
(involves: C57BL/6)
|
abnormal glucose homeostasis
|
J:131694
|
impaired gluconeogenesis
|
J:131694
|
increased insulin sensitivity
|
J:131694
|
Clockm1Jt/Clockm1Jt
(involves: C57BL/6J)
|
decreased insulin secretion
|
J:162641
|
hyperglycemia
|
J:162641
|
impaired glucose tolerance
|
J:162641
|
increased insulin sensitivity
|
J:162641
|
insulin resistance
|
J:162641
|
Clockm1Jt/Clockm1Jt Lepob/Lepob
(involves: BALB/c * C57BL/6 * C57BL/6J * Jcl:ICR)
|
decreased circulating glucose level
|
J:135847
|
decreased circulating insulin level
|
J:135847
|
increased circulating glucose level
|
J:135847
|
increased circulating insulin level
|
J:135847
|
Clpptm1a(EUCOMM)Wtsi/Clpptm1a(EUCOMM)Wtsi
(C57BL/6N-Clpptm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
Clstn3tm1b(EUCOMM)Hmgu/Clstn3tm1b(EUCOMM)Hmgu
(involves: BALB/cJ * C57BL/6N)
|
decreased circulating glucose level
|
J:293885
|
increased insulin sensitivity
|
J:293885
|
Cltrntm1Thu/Y
(involves: 129S/SvEv * C57BL/6)
|
increased insulin sensitivity
|
J:148522
|
Clutm1b(EUCOMM)Hmgu/Clutm1b(EUCOMM)Hmgu
(C57BL/6N-Clutm1b(EUCOMM)Hmgu/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Cluhtm1.1Eir/Cluhtm1.1Eir Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: BALB/cJ * C57BL/6 * DBA * SJL)
|
decreased fasting circulating glucose level
|
J:249661
|
hypoglycemia
|
J:249661
|
Cluhtm1.2Eir/Cluhtm1.2Eir
(involves: BALB/cJ * C57BL/6 * SJL)
|
decreased fasting circulating glucose level
|
J:249661
|
Clvs1tm1.1(KOMP)Vlcg/Clvs1tm1.1(KOMP)Vlcg
(B6N(Cg)-Clvs1tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Cnot3tm1.1Tya/Cnot3+
(B6.129P2(Cg)-Cnot3tm1.1Tya)
|
decreased circulating glucose level
|
J:180033
|
decreased fasting circulating glucose level
|
J:180033
|
improved glucose tolerance
|
J:180033
|
increased insulin sensitivity
|
J:180033
|
Cnot3tm1.1Tya/Cnot3+ Lepob/Lepob
(involves: 129P2/OlaHsd * C57BL/6J)
|
improved glucose tolerance
|
J:180033
|
increased insulin sensitivity
|
J:180033
|
Cnot6ltm1Tya/Cnot6ltm1Tya
(B6.Cg-Cnot6ltm1Tya)
|
abnormal circulating glucose level
|
J:274297
|
abnormal circulating insulin level
|
J:274297
|
Cnr1tm1Ojm/Cnr1tm1Ojm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating insulin level
|
J:93697
|
increased insulin sensitivity
|
J:93697
|
Cog3tm1b(EUCOMM)Hmgu/Cog3+
(C57BL/6N-Cog3tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating insulin level
|
J:211773
|
Col1a1tm1(tetO-Lin28a)Gqda/Col1a1+
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
decreased circulating glucose level
|
J:166568
|
decreased circulating insulin level
|
J:166568
|
improved glucose tolerance
|
J:166568,
J:177113
|
increased insulin sensitivity
|
J:166568,
J:177113
|
Col1a1tm1(tetO-Tcfap2c)Hsc/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
decreased liver glycogen level
|
J:174049
|
Col1a1tm1(tetO-URI1)Ndj/Col1a1+ Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd)
|
decreased circulating glucose level
|
J:217463
|
Col1a1tm2(CAG-IDH2*R172K)Kkw/Col1a1+ Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S4/SvJae * BALB/c * C57BL/6)
|
increased cardiac muscle glycogen level
|
J:209629
|
increased skeletal muscle glycogen level
|
J:209629
|
Col1a1tm2(tetO-Fosl2,-DsRed)Wag/Col1a1+ Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
decreased circulating glucose level
|
J:211215
|
decreased circulating insulin level
|
J:211215
|
decreased insulin secretion
|
J:211215
|
improved glucose tolerance
|
J:211215
|
increased insulin sensitivity
|
J:211215
|
Col1a1tm2(tetO-LIN28B)Gqda/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
hypoglycemia
|
J:177113
|
improved glucose tolerance
|
J:177113
|
increased insulin sensitivity
|
J:177113
|
Col1a1tm3(CAG-IDH2*R140Q)Kkw/Col1a1+ Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S4/SvJae * BALB/c * C57BL/6)
|
increased skeletal muscle glycogen level
|
J:209629
|
Col1a1tm3(tetO-Fosl1,-DsRed)Wag/Col1a1+ Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI)
|
impaired glucose tolerance
|
J:210545
|
insulin resistance
|
J:210545
|
Col1a1tm3(tetO-Mirlet7g/Mir21)Gqda/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
impaired glucose tolerance
|
J:177113
|
increased circulating glucose level
|
J:177113
|
increased circulating insulin level
|
J:177113
|
Col4a5tm1b(EUCOMM)Wtsi/Col4a5tm1b(EUCOMM)Wtsi
(C57BL/6N-Col4a5tm1b(EUCOMM)Wtsi/Cnrm)
|
impaired glucose tolerance
|
J:211773
|
Col5a3tm1Dgr/Col5a3tm1Dgr
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
abnormal glucose homeostasis
|
J:171817
|
decreased circulating insulin level
|
J:171817
|
decreased insulin secretion
|
J:171817
|
hyperglycemia
|
J:171817
|
impaired glucose tolerance
|
J:171817
|
insulin resistance
|
J:171817
|
Col6a1tm1Sngi/Col6a1tm1Sngi
(B6.Cg-Col6a1tm1Sngi)
|
impaired glucose tolerance
|
J:278926
|
Col14a1tm1b(KOMP)Wtsi/Col14a1tm1b(KOMP)Wtsi
(C57BL/6N-Col14a1tm1b(KOMP)Wtsi/Bay)
|
impaired glucose tolerance
|
J:211773
|
Col18a1tm1.1(KOMP)Vlcg/Col18a1tm1.1(KOMP)Vlcg
(B6N(Cg)-Col18a1tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Colca2tm1b(NCOM)Mfgc/Colca2tm1b(NCOM)Mfgc
(C57BL/6N-Colca2tm1b(NCOM)Mfgc/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
Commd9tm1b(KOMP)Wtsi/Commd9+
(C57BL/6N-Commd9tm1b(KOMP)Wtsi/H)
|
impaired glucose tolerance
|
J:211773
|
Cops7atm1b(KOMP)Mbp/Cops7atm1b(KOMP)Mbp
(C57BL/6N-Cops7atm1b(KOMP)Mbp/Ucd)
|
improved glucose tolerance
|
J:211773
|
Coq6tm1b(EUCOMM)Hmgu/Coq6+
(C57BL/6N-Coq6tm1b(EUCOMM)Hmgu/Ics)
|
increased fasting circulating glucose level
|
J:211773
|
Coq8btm1b(EUCOMM)Hmgu/Coq8b+
(B6N(Cg)-Coq8btm1b(EUCOMM)Hmgu/J)
|
decreased fasting circulating glucose level
|
J:211773
|
impaired glucose tolerance
|
J:211773
|
Corttm1Ldl/Corttm1Ldl
(involves: C57BL/6J)
|
increased circulating glucose level
|
J:179095
|
insulin resistance
|
J:179095
|
Cox4i2tm1Hutt/Cox4i2tm1Hutt
(B6.129-Cox4i2tm1Hutt)
|
improved glucose tolerance
|
J:187640
|
Cox7ctm1b(KOMP)Mbp/Cox7c+
(B6N(Cg)-Cox7ctm1b(KOMP)Mbp/J)
|
increased fasting circulating glucose level
|
J:211773
|
Cpb1tm1.1(KOMP)Vlcg/Cpb1tm1.1(KOMP)Vlcg
(B6N(Cg)-Cpb1tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Cpdem1(IMPC)J/Cpd+
(C57BL/6NJ-Cpdem1(IMPC)J/Mmjax)
|
impaired glucose tolerance
|
J:211773
|
Cpefat/Cpefat
(involves: HRS/J)
|
hyperglycemia
|
J:10872
|
hypoglycemia
|
J:13651
|
increased circulating insulin level
|
J:13651,
J:10872
|
Cpefat/Cpefat
(BKSChpLt.HRS-Cpefat/J)
|
hyperglycemia
|
J:10872
|
increased circulating insulin level
|
J:24436,
J:10872
|
Cpefat/Cpefat Find1HRS/J/Find1HRS/J
(involves: C57BLKS/J * HRS/J)
|
increased circulating glucose level
|
J:100832
|
Cpefat/Cpefat Find2C57BLKS/J/Find2C57BLKS/J
(involves: C57BLKS/J * HRS/J)
|
decreased circulating insulin level
|
J:100832
|
increased circulating glucose level
|
J:100832
|
Cpetm1b(EUCOMM)Hmgu/Cpetm1b(EUCOMM)Hmgu
(C57BL/6N-Cpetm1b(EUCOMM)Hmgu/Ieg)
|
impaired glucose tolerance
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cpetm1Yplo/Cpetm1Yplo
(involves: 129S1/Sv * C57BL/6)
|
abnormal glucose homeostasis
|
J:95741
|
impaired glucose tolerance
|
J:95741
|
increased circulating glucose level
|
J:95741
|
increased circulating insulin level
|
J:95741
|
insulin resistance
|
J:95741
|
Cpt1atm1Pwo/Cpt1a+
(either: 129S6/SvEvTac-Cpt1atm1Pwo or (involves: 129S6/SvEvTac * C57BL/6NTac))
|
decreased circulating glucose level
|
J:101934
|
Cpt1ctm1Dhwu/Cpt1ctm1Dhwu
(involves: 129 * C57BL/6J)
|
enhanced gluconeogenesis
|
J:148205
|
increased circulating glucose level
|
J:148205
|
increased circulating insulin level
|
J:148205
|
insulin resistance
|
J:148205
|
Cpt1ctm1Mdln/Cpt1ctm1Mdln
(involves: C57BL/6)
|
insulin resistance
|
J:109455
|
Crattm1.1Pbrc/Crattm1.1Pbrc Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
abnormal glucose homeostasis
|
J:184778
|
impaired glucose tolerance
|
J:184778
|
increased circulating glucose level
|
J:184778
|
insulin resistance
|
J:184778
|
Crbntm1Csp/Crbntm1Csp
(B6N.Cg-Crbntm1Csp)
|
decreased circulating glucose level
|
J:208570
|
decreased circulating insulin level
|
J:208570
|
improved glucose tolerance
|
J:208570
|
increased insulin sensitivity
|
J:208570
|
CrebbpGt(U-San)112Imeg/Crebbp+
(involves: C57BL/6 * CBA)
|
improved glucose tolerance
|
J:75361
|
increased circulating insulin level
|
J:75361
|
increased insulin sensitivity
|
J:75361
|
Crebbptm1Few/Crebbp+
(Not Specified)
|
abnormal glucose homeostasis
|
J:91133
|
decreased circulating glucagon level
|
J:91133
|
impaired glucose tolerance
|
J:91133
|
increased circulating glucose level
|
J:91133
|
increased circulating insulin level
|
J:91133
|
increased liver glycogen level
|
J:91133
|
insulin resistance
|
J:91133
|
Crebbptm1Few/Crebbptm1Few
(Not Specified)
|
abnormal glucose homeostasis
|
J:91133
|
decreased circulating glucagon level
|
J:91133
|
impaired glucose tolerance
|
J:91133
|
increased circulating glucose level
|
J:91133
|
increased circulating insulin level
|
J:91133
|
increased liver glycogen level
|
J:91133
|
Creg1em1Yal/Creg1em1Yal Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
abnormal glucose homeostasis
|
J:263073
|
decreased glycogen level
|
J:263073
|
impaired glucose tolerance
|
J:263073
|
increased circulating insulin level
|
J:263073
|
increased fasting circulating glucose level
|
J:263073
|
insulin resistance
|
J:263073
|
Creg2em1(IMPC)J/Creg2em1(IMPC)J
(C57BL/6NJ-Creg2em1(IMPC)J/Mmjax)
|
decreased fasting circulating glucose level
|
J:211773
|
Crhm1H/Crh+
(involves: C3H/HeH * C57BL/6J)
|
abnormal glucose homeostasis
|
J:208708
|
hyperglycemia
|
J:208708
|
impaired glucose tolerance
|
J:208708
|
increased circulating glucagon level
|
J:208708
|
increased circulating insulin level
|
J:208708
|
increased urine glucose level
|
J:208708
|
insulin resistance
|
J:208708
|
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal circulating glucose level
|
J:23082
|
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6)
|
abnormal circulating glucose level
|
J:102987,
J:105629
|
Crhr2tm1Klee/Crhr2tm1Klee
(involves: 129S4/SvJae * C57BL/6)
|
abnormal glucose homeostasis
|
J:83683
|
increased insulin sensitivity
|
J:83683
|
Crispld2tm1Lex/Crispld2tm1Lex
(B6;129S5-Crispld2tm1Lex/Mmucd)
|
improved glucose tolerance
|
J:171883
|
Crls1tm1Geno/Crls1tm1Geno Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ)
|
increased fasting circulating glucose level
|
J:266083
|
insulin resistance
|
J:266083
|
Crls1tm1Geno/Crls1tm1Geno Tg(Ucp1-cre/ERT2)426Biat/0
(involves: C57BL/6N)
|
insulin resistance
|
J:266083
|
Crtc1Gt(XK522)Byg/Crtc1Gt(XK522)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
hyperglycemia
|
J:142448
|
impaired glucose tolerance
|
J:142448
|
increased circulating insulin level
|
J:142448
|
Crtc2tm1.1Khk/Crtc2tm1.1Khk
(involves: C57BL/6 * C57BL/6J * FVB/N)
|
abnormal glucose homeostasis
|
J:151618
|
decreased glycogen level
|
J:151618
|
Crtc2tm1Mmy/Crtc2tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased circulating insulin level
|
J:157556
|
decreased fasting circulating glucose level
|
J:157556
|
decreased hepatic glucose production
|
J:157556
|
impaired gluconeogenesis
|
J:157556
|
increased insulin sensitivity
|
J:157556
|
Crtc3tm1Mmy/Crtc3tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal glucose homeostasis
|
J:167211
|
decreased circulating insulin level
|
J:167211
|
increased insulin sensitivity
|
J:167211
|
Crxem1(IMPC)Ccpcz/Crxem1(IMPC)Ccpcz
(C57BL/6N-Crxem1(IMPC)Ccpcz/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Cry1tm1Asn/Cry1tm1Asn Cry2tm1Asn/Cry2tm1Asn
(involves: 129P2/OlaHsd * C57BL/6)
|
impaired glucose tolerance
|
J:128437
|
increased insulin sensitivity
|
J:128437
|
Cstm1.1(KOMP)Wtsi/Cs+
(C57BL/6N-Cstm1.1(KOMP)Wtsi/Ieg)
|
impaired glucose tolerance
|
J:211773
|
Csf2tm1Mlg/Csf2tm1Mlg
(B6.129S2-Csf2tm1Mlg)
|
increased circulating glucose level
|
J:145518
|
Csf2tm1Mlg/Csf2tm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
abnormal circulating glucose level
|
J:142440
|
decreased circulating insulin level
|
J:142440
|
enhanced gluconeogenesis
|
J:142440
|
Csf2tm1Mlg/Csf2tm1Mlg Il3tm1Glli/Il3tm1Glli
(B6.129S2-Csf2tm1Mlg Il3tm1Glli)
|
hyperglycemia
|
J:145518
|
impaired glucose tolerance
|
J:145518
|
Csmd1tm1Lex/Csmd1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6NTac)
|
improved glucose tolerance
|
J:209700
|
Csnk1g2tm1b(EUCOMM)Wtsi/Csnk1g2tm1b(EUCOMM)Wtsi
(C57BL/6N-Csnk1g2tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating glucose level
|
J:211773
|
Csnk2a2em1(IMPC)Mbp/Csnk2a2em1(IMPC)Mbp
(C57BL/6N-Csnk2a2em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating glucose level
|
J:211773
|
Cspg4tm1Wbst/Cspg4tm1Wbst
(involves: 129S1/Sv * 129X1/SvJ)
|
impaired glucose tolerance
|
J:184220
|
insulin resistance
|
J:184220
|
Ctdspltm1.1(KOMP)Mbp/Ctdspltm1.1(KOMP)Mbp
(C57BL/6N-Ctdspltm1.1(KOMP)Mbp/Ucd)
|
impaired glucose tolerance
|
J:211773
|
Ctf1tm1Msd/Ctf1tm1Msd
(B6.Cg-Ctf1tm1Msd)
|
hyperglycemia
|
J:176727
|
increased circulating insulin level
|
J:176727
|
insulin resistance
|
J:176727
|
Cthrc1tm1Vli/Cthrc1tm1Vli
(129S6.Cg-Cthrc1tm1Vli)
|
increased circulating glucose level
|
J:192096
|
increased liver glycogen level
|
J:192096
|
increased skeletal muscle glycogen level
|
J:192096
|
insulin resistance
|
J:192096
|
Ctsbtm1Jde/Ctsb+
(NOD.129P2-Ctsbtm1Jde)
|
hyperglycemia
|
J:153355
|
Ctsbtm1Jde/Ctsbtm1Jde
(NOD.129P2-Ctsbtm1Jde)
|
hyperglycemia
|
J:153355
|
Ctsltm1Cptr/Ctsl+
(NOD.129P2-Ctsltm1Cptr)
|
hyperglycemia
|
J:153355
|
Ctsmtm1(KOMP)Wtsi/Ctsmtm1(KOMP)Wtsi
(C57BL/6N-Ctsmtm1(KOMP)Wtsi/Nju)
|
increased fasting circulating glucose level
|
J:211773
|
Ctsstm1Eae/Ctss+
(NOD.D1-Ctsstm1Eae)
|
hyperglycemia
|
J:153355
|
Ctsstm1Eae/Ctsstm1Eae
(NOD.D1-Ctsstm1Eae)
|
hyperglycemia
|
J:153355
|
Cul4atm1b(EUCOMM)Hmgu/Cul4atm1b(EUCOMM)Hmgu
(C57BL/6N-Cul4atm1b(EUCOMM)Hmgu/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Cxadrtm1Dvst/Cxadrtm1Dvst
(involves: 129X1/SvJ * C57BL/6)
|
increased cardiac muscle glycogen level
|
J:100174
|
Cxcl9tm1b(EUCOMM)Wtsi/Cxcl9tm1b(EUCOMM)Wtsi
(C57BL/6N-Cxcl9tm1b(EUCOMM)Wtsi/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Cxcl14tm1Tha/Cxcl14tm1Tha
(involves: C57BL/6 * CBA)
|
decreased circulating glucose level
|
J:126841
|
decreased circulating insulin level
|
J:126841
|
impaired glucose tolerance
|
J:126841
|
improved glucose tolerance
|
J:126841
|
increased insulin sensitivity
|
J:126841
|
Cxcr1tm1a(EUCOMM)Wtsi/Cxcr1tm1a(EUCOMM)Wtsi
(C57BL/6N-Cxcr1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cxcr2tm1a(EUCOMM)Wtsi/Cxcr2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cxcr2tm1a(EUCOMM)Wtsi/Wtsi)
|
improved glucose tolerance
|
J:211773
|
Cxcr3tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating glucose level
|
J:101679
|
Cyb5r4tm1Hfb/Cyb5r4tm1Hfb
(involves: 129S4/SvJae * BALB/cAnN)
|
abnormal glucose homeostasis
|
J:91486
|
decreased circulating insulin level
|
J:91486
|
decreased insulin secretion
|
J:91486
|
impaired glucose tolerance
|
J:91486
|
increased circulating glucose level
|
J:91486
|
increased insulin sensitivity
|
J:91486
|
Cyb561tm1b(EUCOMM)Wtsi/Cyb561tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyb561tm1b(EUCOMM)Wtsi/H)
|
decreased circulating glucose level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Cyb561a3tm2b(EUCOMM)Hmgu/Cyb561a3tm2b(EUCOMM)Hmgu
(C57BL/6N-Cyb561a3tm2b(EUCOMM)Hmgu/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Cybbtm1.1Abk/Cybbtm1.1Abk Lyz2tm1(cre)Ifo/?
(B6.Cg-Lyz2tm1(cre)Ifo Cybbtm1.1Abk)
|
decreased circulating insulin level
|
J:245699
|
decreased fasting circulating glucose level
|
J:245699
|
Cybc1tm1a(KOMP)Wtsi/Cybc1tm1a(KOMP)Wtsi
(C57BL/6N-Cybc1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:175295
|
Cyp4b1tm1b(KOMP)Wtsi/Cyp4b1tm1b(KOMP)Wtsi
(C57BL/6N-Cyp4b1tm1b(KOMP)Wtsi/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Cyp4f16tm1b(KOMP)Wtsi/Cyp4f16tm1b(KOMP)Wtsi
(C57BL/6N-Cyp4f16tm1b(KOMP)Wtsi/H)
|
increased fasting circulating glucose level
|
J:211773
|
Cyp7b1tm1b(EUCOMM)Wtsi/Cyp7b1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyp7b1tm1b(EUCOMM)Wtsi/Bay)
|
impaired glucose tolerance
|
J:211773
|
Cyp11b1tm1Chjk/Cyp11b1tm1Chjk
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating insulin level
|
J:147610
|
impaired glucose tolerance
|
J:147610
|
Cyp17a1tm1b(EUCOMM)Wtsi/Cyp17a1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyp17a1tm1b(EUCOMM)Wtsi/Nju)
|
improved glucose tolerance
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cyp19a1tm1b(EUCOMM)Hmgu/Cyp19a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp19a1tm1b(EUCOMM)Hmgu/H)
|
increased fasting circulating glucose level
|
J:211773
|
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac)
|
abnormal glucose homeostasis
|
J:65805
|
increased circulating insulin level
|
J:65805
|
Cyp19a1tm1Toda/Cyp19a1tm1Toda
(involves: 129P2/OlaHsd * C57BL/6J)
|
impaired glucose tolerance
|
J:82070
|
increased circulating glucose level
|
J:82070
|
insulin resistance
|
J:82070
|
Cyp27a1tm1.1(KOMP)Vlcg/Cyp27a1tm1.1(KOMP)Vlcg
(C57BL/6N-Cyp27a1tm1.1(KOMP)Vlcg/Ucd)
|
improved glucose tolerance
|
J:211773
|
Cyth3tm2a(KOMP)Wtsi/Cyth3tm2a(KOMP)Wtsi
(C57BL/6N-Cyth3tm2a(KOMP)Wtsi)
|
decreased circulating glucose level
|
J:272118
|
decreased liver glycogen level
|
J:272118
|
insulin resistance
|
J:272118
|
D6Wsu163etm1b(EUCOMM)Wtsi/D6Wsu163etm1b(EUCOMM)Wtsi
(C57BL/6N-D6Wsu163etm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
D630045J12Riktm1b(KOMP)Wtsi/D630045J12Riktm1b(KOMP)Wtsi
(C57BL/6N-D630045J12Riktm1b(KOMP)Wtsi/Tcp)
|
improved glucose tolerance
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Daam2tm1a(KOMP)Wtsi/Daam2tm1a(KOMP)Wtsi
(C57BL/6N-Daam2tm1a(KOMP)Wtsi/Wtsi)
|
increased fasting circulating glucose level
|
J:211773
|
Dact3tm1b(KOMP)Wtsi/Dact3tm1b(KOMP)Wtsi
(C57BL/6N-Dact3tm1b(KOMP)Wtsi/Wtsi)
|
improved glucose tolerance
|
J:211773
|
Dbhtm1Rpa/Dbhtm1Rpa
(involves: 129S7/SvEvBrd * 129/SvCPJ * C57BL/6J)
|
abnormal glucose homeostasis
|
J:85772
|
decreased circulating glucagon level
|
J:85772
|
decreased circulating glucose level
|
J:85772
|
decreased glucagon secretion
|
J:85772
|
increased circulating insulin level
|
J:85772
|
insulin resistance
|
J:85772
|
Dbil5tm1(KOMP)Wtsi/Dbil5tm1(KOMP)Wtsi
(C57BL/6N-Dbil5tm1(KOMP)Wtsi/Nju)
|
increased circulating glucose level
|
J:211773
|
Dbm1A/J/Dbm1A/J Ins2Akita/Ins2+
(involves: A/J * C57BL/6J * C57BL/6NSlc)
|
increased circulating glucose level
|
J:112869
|
increased circulating insulin level
|
J:112869
|
Dbm2C57BL/6J/?
(involves: A/J * C57BL/6J)
|
abnormal glucose homeostasis
|
J:112869
|
increased circulating glucose level
|
J:112869
|
Dbm3C57BL/6J/? Ins2Akita/Ins2+
(involves: A/J * C57BL/6J * C57BL/6NSlc)
|
abnormal circulating glucose level
|
J:112869
|
Dbm4C57BL/6J/? Ins2Akita/Ins2+
(involves: A/J * C57BL/6J * C57BL/6NSlc)
|
abnormal circulating glucose level
|
J:112869
|
Dbnltm1b(KOMP)Wtsi/Dbnltm1b(KOMP)Wtsi
(C57BL/6N-Dbnltm1b(KOMP)Wtsi/Orl)
|
increased circulating glucose level
|
J:211773
|
Dbsq3C3H/HeJ/Dbsq3C3H/HeJ Leprdb/Lepr+
(involves: C3H/HeJ * C57BLKS)
|
increased circulating glucose level
|
J:116038
|
Dbsq3C57BLKS/J/Dbsq3C3H/HeJ Leprdb/Lepr+
(involves: C3H/HeJ * C57BLKS)
|
increased circulating glucose level
|
J:116038
|
Dbsty1NZO/HlLt/Dbsty1NON/ShiLtJ
(involves: NON/Lt * NZO/HlLt)
|
hyperglycemia
|
J:65256
|
increased circulating insulin level
|
J:65256
|
Dbsty1NZO/HlLt/Dbsty1NZO/HlLt
(involves: NON/Lt * NZO/HlLt)
|
hyperglycemia
|
J:65256
|
increased circulating insulin level
|
J:65256
|
Dbsty3NON/ShiLtJ/Dbsty3NZO/HlLt
(involves: NON/Lt * NZO/HlLt)
|
insulin resistance
|
J:65256
|
Dbsty3NZO/HlLt/Dbsty3NZO/HlLt
(involves: NON/Lt * NZO/HlLt)
|
insulin resistance
|
J:65256
|
Dbsty4NZO/HlLt/Dbsty4NON/ShiLtJ
(involves: NON/Lt * NZO/HlLt)
|
hyperglycemia
|
J:65256
|
Dbsty4NZO/HlLt/Dbsty4NZO/HlLt
(involves: NON/Lt * NZO/HlLt)
|
hyperglycemia
|
J:65256
|
Dbts1SM/J/?
(involves: LG/J * SM/J)
|
impaired glucose tolerance
|
J:94605
|
Dbts2SM/J/?
(involves: LG/J * SM/J)
|
impaired glucose tolerance
|
J:94605
|
Dcun1d3em1(IMPC)Wtsi/Dcun1d3em1(IMPC)Wtsi
(C57BL/6N-Dcun1d3em1(IMPC)Wtsi/WtsiIeg)
|
decreased circulating glucose level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
improved glucose tolerance
|
J:211773
|
Dcxtm1a(EUCOMM)Wtsi/Y
(C57BL/6N-Dcxtm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
Ddi2tm1b(EUCOMM)Hmgu/Ddi2+
(C57BL/6N-Ddi2tm1b(EUCOMM)Hmgu/Ccpcz)
|
impaired glucose tolerance
|
J:211773
|
Ddit3tm2.1Dron/Ddit3tm2.1Dron
(B6.129S(Cg)-Ddit3tm2.1Dron/J)
|
impaired glucose tolerance
|
J:214136
|
insulin resistance
|
J:214136
|
Ddr2slie/Ddr2slie
(BKSChpLt.Cg-Tg(Ins2-Cpe)1Lt Cpefat/LtJng)
|
increased circulating glucose level
|
J:134371
|
Ddx58em1(IMPC)Mbp/Ddx58em1(IMPC)Mbp
(C57BL/6N-Ddx58em1(IMPC)Mbp/MbpMmucd)
|
impaired glucose tolerance
|
J:211773
|
Decr1tm1Jkh/Decr1tm1Jkh
(B6.129X1-Decr1tm1Jkh)
|
decreased circulating glucose level
|
J:151622
|
Defb20tm1b(EUCOMM)Hmgu/Defb20tm1b(EUCOMM)Hmgu
(C57BL/6N-Defb20tm1b(EUCOMM)Hmgu/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Degs1Gt(OST368559)Lex/Degs1+
(involves: 129S5/SvEvBrd)
|
increased insulin sensitivity
|
J:203554
|
Del(7)Tyrc-3H/Del(7)Tyrc-3H
(involves: 101/H * C3H/HeH)
|
decreased circulating glucose level
|
J:5063
|
hypoglycemia
|
J:5063
|
Del(7Ffar2-Ffar3)1Soff/Del(7Ffar2-Ffar3)1Soff
(involves: 129S4/SvJae * C57BL/6)
|
abnormal insulin secretion
|
J:227939
|
improved glucose tolerance
|
J:227939
|
increased circulating insulin level
|
J:227939
|
Del(MTmt-Tk-mt-Nd5)1Jiha
(involves: C57BL/6J * CBA)
|
decreased circulating glucose level
|
J:92536
|
increased circulating insulin level
|
J:92536
|
increased insulin secretion
|
J:92536
|
Del(MTmt-Tk-mt-Nd5)1Jiha
(involves: C57BL/6JJcl * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased circulating glucose level
|
J:199416
|
Dennd5bem1(IMPC)Tcp/Dennd5bem1(IMPC)Tcp
(C57BL/6N-Dennd5bem1(IMPC)Tcp/Tcp)
|
decreased circulating glucose level
|
J:211773
|
improved glucose tolerance
|
J:211773
|
Depdc5tm1b(EUCOMM)Hmgu/Depdc5+
(C57BL/6N-Depdc5tm1b(EUCOMM)Hmgu/H)
|
impaired glucose tolerance
|
J:211773
|
Deptortm1.1Mala/Deptortm1.1Mala Speer6-ps1Tg(Alb-cre)21Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 x DBA)
|
decreased fasting circulating glucose level
|
J:275931
|
decreased liver glycogen level
|
J:275931
|
increased insulin sensitivity
|
J:275931
|
Derl2tm1.2Hpl/Derl2tm1.2Hpl
(involves: BALB/cJ)
|
hypoglycemia
|
J:170650
|
Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating glucose level
|
J:111346
|
improved glucose tolerance
|
J:111346
|
increased insulin sensitivity
|
J:61885
|
Dgat2tm1Far/Dgat2tm1Far
(involves: 129S4/SvJae * C57BL/6J)
|
decreased liver glycogen level
|
J:88742
|
hypoglycemia
|
J:88742
|
Dgkdem1(IMPC)H/Dgkd+
(C57BL/6NTac-Dgkdem1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Dguoktm1.1Anka/Dguoktm1.1Anka
(involves: 129 * C57BL/6N)
|
decreased circulating glucose level
|
J:294620
|
Dhtkd1tm1Zgwg/Dhtkd1tm1Zgwg
(involves: C57BL/6)
|
decreased circulating glucose level
|
J:267178
|
improved glucose tolerance
|
J:267178
|
increased circulating insulin level
|
J:267178
|
increased insulin secretion
|
J:267178
|
increased insulin sensitivity
|
J:267178
|
increased liver glycogen level
|
J:267178
|
Dhx30tm1.1(KOMP)Vlcg/Dhx30+
(C57BL/6N-Dhx30tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Dibg1129S6/SvEvTac/Dibg1129S6/SvEvTac
(involves: 129S6/SvEvTac * C57BL/6)
|
hyperglycemia
|
J:142949
|
Dis3tm1e.1(EUCOMM)Hmgu/Dis3+
(C57BL/6N-Dis3tm1e.1(EUCOMM)Hmgu/Ieg)
|
impaired glucose tolerance
|
J:211773
|
Diwg1C57BL/6/Diwg1C57BL/6
(involves: 129S6/SvEvTac * C57BL/6)
|
hyperglycemia
|
J:142949
|
Dkk1tm1.1Svo/Dkk1tm1.2Svo Pax8tm1.1(cre)Mbu/Pax8+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased urine glucose level
|
J:173125
|
Dlgap4tm1b(KOMP)Wtsi/Dlgap4+
(C57BL/6N-Dlgap4tm1b(KOMP)Wtsi/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
Dlk1em1(IMPC)Wtsi/Dlk1em1(IMPC)Wtsi
(C57BL/6N-Dlk1em1(IMPC)Wtsi/WtsiIeg)
|
decreased circulating glucose level
|
J:211773
|
Dmbx1tm1Sse/Dmbx1tm1Sse Lepob/Lepob
(involves: ICR)
|
abnormal circulating glucose level
|
J:125193
|
Dnaja4tm1b(KOMP)Wtsi/Dnaja4tm1b(KOMP)Wtsi
(C57BL/6N-Dnaja4tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
Dnajb3tm1.1(KOMP)Vlcg/Dnajb3tm1.1(KOMP)Vlcg
(C57BL/6N-Dnajb3tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Dnajb7tm1.1(KOMP)Vlcg/Dnajb7tm1.1(KOMP)Vlcg
(C57BL/6N-Dnajb7tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg
(129P2/OlaHsd-Dnajb9Gt(KST256)Byg)
|
decreased liver glycogen level
|
J:226674
|
hypoglycemia
|
J:226674
|
increased circulating glucagon level
|
J:226674
|
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg
(B6.129P2-Dnajb9Gt(KST256)Byg)
|
abnormal circulating glucose level
|
J:226674
|
decreased circulating insulin level
|
J:226674
|
decreased liver glycogen level
|
J:226674
|
hypoglycemia
|
J:226674
|
increased circulating glucagon level
|
J:226674
|
Dnajc3tm8663Wcl/Dnajc3tm8663Wcl
(C57BL/6-Dnajc3tm8663Wcl/Mmmh)
|
hyperglycemia
|
J:98194
|
increased circulating insulin level
|
J:98194
|
increased urine glucose level
|
J:98194
|
Dnajc5gtm1.1(KOMP)Vlcg/Dnajc5g+
(C57BL/6N-Dnajc5gtm1.1(KOMP)Vlcg/J)
|
increased circulating insulin level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Dnajc15Gt(RRN226)Byg/Dnajc15Gt(RRN226)Byg
(B6.129P2-Dnajc15Gt(RRN226)Byg)
|
abnormal glycogen homeostasis
|
J:204025
|
increased glycogen level
|
J:204025
|
increased kidney glycogen level
|
J:204025
|
increased liver glycogen level
|
J:204025
|
Dnajc15tm1b(KOMP)Wtsi/Dnajc15tm1b(KOMP)Wtsi
(C57BL/6N-Dnajc15tm1b(KOMP)Wtsi/Bay)
|
increased circulating glucose level
|
J:211773
|
Dnajc19tm1a(EUCOMM)Hmgu/Dnajc19tm1a(EUCOMM)Hmgu
(C57BL/6N-Dnajc19tm1a(EUCOMM)Hmgu/H)
|
increased circulating glucose level
|
J:165965
|
Dnajc30tm1.1(KOMP)Vlcg/Dnajc30tm1.1(KOMP)Vlcg
(C57BL/6N-Dnajc30tm1.1(KOMP)Vlcg/J)
|
improved glucose tolerance
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/J)
|
increased fasting circulating glucose level
|
J:211773
|
Dok1tm1Yyam/Dok1tm1Yyam
(B6.129S4-Dok1tm1Yyam)
|
decreased circulating insulin level
|
J:133566
|
improved glucose tolerance
|
J:133566
|
increased insulin sensitivity
|
J:133566
|
Dpm2tm1b(EUCOMM)Hmgu/Dpm2+
(C57BL/6N-Dpm2tm1b(EUCOMM)Hmgu/H)
|
impaired glucose tolerance
|
J:211773
|
Dpp4tm1b(EUCOMM)Wtsi/Dpp4tm1b(EUCOMM)Wtsi
(C57BL/6N-Dpp4tm1b(EUCOMM)Wtsi/Ics)
|
improved glucose tolerance
|
J:211773
|
Dpp4tm1Lex/Dpp4tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J)
|
improved glucose tolerance
|
J:195941
|
Dpp4tm1Nwa/Dpp4tm1Nwa
(C57BL/6-Dpp4tm1Nwa)
|
improved glucose tolerance
|
J:62709
|
increased circulating glucagon level
|
J:62709
|
increased circulating insulin level
|
J:62709
|
increased insulin secretion
|
J:62709
|
Dpp8em1(IMPC)J/Dpp8em1(IMPC)J
(C57BL/6NJ-Dpp8em1(IMPC)J/Mmjax)
|
impaired glucose tolerance
|
J:211773
|
Draxintm1Lex/Draxintm1Lex
(B6;129S5-Draxintm1Lex/Mmucd)
|
decreased circulating insulin level
|
J:171883
|
Dsg1cem1(IMPC)Mbp/Dsg1cem1(IMPC)Mbp
(C57BL/6N-Dsg1cem1(IMPC)Mbp/Ucd)
|
increased circulating glucose level
|
J:211773
|
Dspptm1.1(KOMP)Vlcg/Dspptm1.1(KOMP)Vlcg
(C57BL/6N-Dspptm1.1(KOMP)Vlcg/Ucd)
|
improved glucose tolerance
|
J:211773
|
Dtnbp1tm1b(EUCOMM)Hmgu/Dtnbp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Dtnbp1tm1b(EUCOMM)Hmgu/Tcp)
|
impaired glucose tolerance
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Dtx4em1(IMPC)Ccpcz/Dtx4+
(C57BL/6N-Dtx4em1(IMPC)Ccpcz/Ccpcz)
|
impaired glucose tolerance
|
J:211773
|
Duox2em1(IMPC)Mbp/Duox2em1(IMPC)Mbp
(C57BL/6N-Duox2em1(IMPC)Mbp/MbpMmucd)
|
increased fasting circulating glucose level
|
J:211773
|
Duoxa2tm1b(KOMP)Wtsi/Duoxa2tm1b(KOMP)Wtsi
(C57BL/6N-Duoxa2tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
improved glucose tolerance
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
increased hepatic glucose production
|
J:129718
|
Dusp3tm1b(KOMP)Wtsi/Dusp3tm1b(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Dusp3tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
Dusp4tm1a(EUCOMM)Wtsi/Dusp4tm1a(EUCOMM)Wtsi
(C57BL/6N-Dusp4tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:175295
|
Dusp26em1Jhxia/Dusp26em1Jhxia Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
decreased liver glycogen level
|
J:279111
|
impaired glucose tolerance
|
J:279111
|
increased circulating glucose level
|
J:279111
|
increased fasting circulating glucose level
|
J:279111
|
insulin resistance
|
J:279111
|
Dync1h1tm1dIcs/Dync1h1+
(C57BL/6N-Dync1h1tm1dIcs/Ics)
|
impaired glucose tolerance
|
J:211773
|
Dynll1tm1(KOMP)Wtsi/Dynll1+
(C57BL/6N-Dynll1tm1(KOMP)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
Dynlrb2tm1a(KOMP)Wtsi/Dynlrb2+
(C57BL/6N-Dynlrb2tm1a(KOMP)Wtsi/Wtsi)
|
increased fasting circulating glucose level
|
J:211773
|
E2f1tm1Njd/E2f1tm1Njd
(involves: 129S2/SvPas * C57BL/6)
|
abnormal circulating insulin level
|
J:89720
|
decreased circulating glucose level
|
J:89720
|
decreased circulating insulin level
|
J:89720
|
decreased insulin secretion
|
J:89720
|
impaired glucose tolerance
|
J:89720
|
increased insulin sensitivity
|
J:89720
|
Edn2tm1.1Nat/Edn2tm1.1Nat Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased circulating glucose level
|
J:201436
|
Edn2tm1Ywa/Edn2tm1Ywa
(involves: 129S6/SvEvTac)
|
decreased circulating glucose level
|
J:201436
|
Eef2kmttm1b(EUCOMM)Wtsi/Eef2kmttm1b(EUCOMM)Wtsi
(C57BL/6N-Eef2kmttm1b(EUCOMM)Wtsi/Ieg)
|
impaired glucose tolerance
|
J:211773
|
Efna5tm1b(EUCOMM)Wtsi/Efna5tm1b(EUCOMM)Wtsi
(C57BL/6N-Efna5tm1b(EUCOMM)Wtsi/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Efr3bem1(IMPC)Mbp/Efr3bem1(IMPC)Mbp
(C57BL/6N-Efr3bem1(IMPC)Mbp/Ucd)
|
impaired glucose tolerance
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Egfem1em1(IMPC)J/Egfem1em1(IMPC)J
(C57BL/6NJ-Egfem1em1(IMPC)J/J)
|
decreased fasting circulating glucose level
|
J:211773
|
impaired glucose tolerance
|
J:211773
|
Ehmt1tm1.1Tara/Ehmt1tm1.1Tara Tg(Adipoq-cre)1Evdr/0
(involves: 129P2/OlaHsd * FVB/NJ)
|
impaired glucose tolerance
|
J:207678
|
increased circulating glucose level
|
J:207678
|
increased circulating insulin level
|
J:207678
|
insulin resistance
|
J:207678
|
Eif2ak3tm1Drc/Eif2ak3tm1Drc
(involves: 129S6/SvEvTac)
|
abnormal insulin secretion
|
J:76661
|
decreased circulating insulin level
|
J:76661
|
hyperglycemia
|
J:76661
|
impaired glucose tolerance
|
J:76661
|
increased liver glycogen level
|
J:76661
|
Eif2ak3tm1Dron/Eif2ak3+
(either: 129S6/SvEvTac-Eif2ak3tm1Dron or (involves: 129S6/SvEvTac * C57BL/6))
|
impaired glucose tolerance
|
J:70005
|
Eif2ak3tm1Dron/Eif2ak3tm1Dron
(involves: 129S6/SvEvTac * Swiss Webster)
|
decreased circulating insulin level
|
J:70005
|
hyperglycemia
|
J:70005
|
Eif2b5tm1a(EUCOMM)Wtsi/Eif2b5+
(C57BL/6N-Eif2b5tm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating glucose level
|
J:165965
|
Eif2s1tm1Rjk/Eif2s1tm1Rjk
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating insulin level
|
J:70004
|
decreased insulin secretion
|
J:70004
|
hypoglycemia
|
J:70004
|
Eif2s1tm1Rjk/Eif2s1tm1Rjk Ppp1r15btm1Dron/Ppp1r15btm1Dron
(involves: 129P2/OlaHsd)
|
hypoglycemia
|
J:144954
|
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso
(involves: 129S4/SvJae * BALB/c)
|
hypoglycemia
|
J:72217
|
Eif4g2tm1b(KOMP)Wtsi/Eif4g2+
(C57BL/6N-Eif4g2tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
impaired glucose tolerance
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Elapor1tm1b(EUCOMM)Hmgu/Elapor1+
(C57BL/6N-Elapor1tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating glucose level
|
J:211773
|
Elk1tm1.1(KOMP)Vlcg/Y
(C57BL/6N-Elk1tm1.1(KOMP)Vlcg/J)
|
increased circulating insulin level
|
J:211773
|
Elmo1tm1a(EUCOMM)Wtsi/Elmo1tm1a(EUCOMM)Wtsi
(C57BL/6N-Elmo1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
Elmod1tm1a(EUCOMM)Hmgu/Elmod1tm1a(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1a(EUCOMM)Hmgu/H)
|
decreased circulating glucose level
|
J:165965
|
Elof1tm1.1(KOMP)Vlcg/Elof1+
(C57BL/6N-Elof1tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Elovl6Gt(OST222498)Lex/Elovl6Gt(OST222498)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating insulin level
|
J:130031
|
improved glucose tolerance
|
J:130031
|
increased insulin sensitivity
|
J:130031
|
ElptC57BL/6J/ElptC57BL/6J HypnC57BL/6/HypnC57BL/6
(involves: 129S6/SvEvTac * C57BL/6-Insrtm1Dac Irs1tm1Jos)
|
increased circulating insulin level
|
J:83539
|
Emc4tm1(KOMP)Wtsi/Emc4+
(C57BL/6N-Emc4tm1(KOMP)Wtsi/Nju)
|
increased fasting circulating glucose level
|
J:211773
|
Emc10Gt(OST181617)Lex/Emc10Gt(OST181617)Lex
(B6;129S5-Emc10Gt(OST181617)Lex/Mmucd)
|
improved glucose tolerance
|
J:171883
|
Emc10tm1b(EUCOMM)Wtsi/Emc10tm1b(EUCOMM)Wtsi
(C57BL/6N-Emc10tm1b(EUCOMM)Wtsi/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Eml1em1(IMPC)Wtsi/Eml1em1(IMPC)Wtsi
(C57BL/6N-Eml1em1(IMPC)Wtsi/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
Eml2tm1b(EUCOMM)Wtsi/Eml2tm1b(EUCOMM)Wtsi
(C57BL/6N-Eml2tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating glucose level
|
J:211773
|
Enc1tm1a(EUCOMM)Wtsi/Enc1tm1a(EUCOMM)Wtsi
(C57BL/6N-Enc1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
Enhotm1.1Butl/Enho+
(B6.Cg-Enhotm1.1Butl)
|
impaired glucose tolerance
|
J:225402
|
Enhotm1.1Butl/Enhotm1.1Butl
(B6.Cg-Enhotm1.1Butl)
|
impaired glucose tolerance
|
J:225402
|
increased circulating insulin level
|
J:225402
|
increased fasting circulating glucose level
|
J:225402
|
insulin resistance
|
J:225402
|
Entpd1tm1a(EUCOMM)Wtsi/Entpd1tm1a(EUCOMM)Wtsi
(C57BL/6N-Entpd1tm1a(EUCOMM)Wtsi/Ieg)
|
abnormal glucose homeostasis
|
J:165965
|
Entpd5tm1Rre/Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J)
|
hypoglycemia
|
J:163795
|
Epb41l4atm1b(KOMP)Mbp/Epb41l4atm1b(KOMP)Mbp
(C57BL/6N-Epb41l4atm1b(KOMP)Mbp/J)
|
decreased circulating glucose level
|
J:211773
|
Epg5em1(IMPC)H/Epg5em1(IMPC)H
(C57BL/6NTac-Epg5em1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
epi/?
(involves: CBA/J)
|
decreased circulating glucose level
|
J:5421
|
Epm2atm1Kzy/Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J)
|
hypoglycemia
|
J:173769
|
improved glucose tolerance
|
J:173769
|
increased cardiac muscle glycogen level
|
J:173769
|
increased insulin sensitivity
|
J:173769
|
Epm2aip1Gt(BA0314)Wtsi/Epm2aip1Gt(BA0314)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal gluconeogenesis
|
J:204966
|
abnormal glucose homeostasis
|
J:204966
|
abnormal glycogen homeostasis
|
J:204966
|
decreased circulating glucose level
|
J:204966
|
decreased liver glycogen level
|
J:204966
|
improved glucose tolerance
|
J:204966
|
Eprstm1.1Xen/Eprstm1.1Xen
(C57BL/6-Eprstm1.1Xen)
|
impaired glucose tolerance
|
J:244749
|
increased insulin sensitivity
|
J:244749
|
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased circulating glucose level
|
J:117488
|
decreased circulating insulin level
|
J:117488
|
Ercc5tm2b(EUCOMM)Hmgu/Ercc5+
(C57BL/6N-Ercc5tm2b(EUCOMM)Hmgu/Bay)
|
increased fasting circulating glucose level
|
J:211773
|
Ercc6tm1Gvh/Ercc6tm1Gvh Xpatm1Hvs/Xpatm1Hvs
(B6.129P2-Xpatm1Hvs Ercc6tm1Gvh)
|
hypoglycemia
|
J:122013
|
increased liver glycogen level
|
J:122013
|
Ermp1tm1.1(KOMP)Vlcg/Ermp1tm1.1(KOMP)Vlcg
(C57BL/6N-Ermp1tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Ern1tm1Dron/Ern1+
(129S.129S6-Ern1tm1Dron)
|
abnormal glucose homeostasis
|
J:132805
|
Ero1aGt(XST171)Byg/Ero1aGt(XST171)Byg Ero1bGt(P077G11)Wrst/Ero1bGt(P077G11)Wrst
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
impaired glucose tolerance
|
J:158805
|
Ero1bGt(P077G11)Wrst/Ero1b+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal glucose homeostasis
|
J:158805
|
decreased insulin secretion
|
J:158805
|
impaired glucose tolerance
|
J:158805
|
increased circulating glucose level
|
J:158805
|
Ero1bGt(P077G11)Wrst/Ero1b+ Ins2Akita/Ins2+
(involves: 129S2/SvPas * C57BL/6NSlc)
|
decreased insulin secretion
|
J:158805
|
impaired glucose tolerance
|
J:158805
|
increased circulating glucose level
|
J:158805
|
Ero1bGt(P077G11)Wrst/Ero1bGt(P077G11)Wrst
(involves: 129S2/SvPas * C57BL/6)
|
abnormal glucose homeostasis
|
J:158805
|
decreased insulin secretion
|
J:158805
|
impaired glucose tolerance
|
J:158805
|
increased circulating glucose level
|
J:158805
|
Esr1tm1.1Gust/Esr1tm1.1Gust
(B6.129X1-Esr1tm1.1Gust)
|
increased circulating glucose level
|
J:186230
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J)
|
insulin resistance
|
J:66077
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd)
|
impaired glucose tolerance
|
J:151012
|
increased circulating glucose level
|
J:151012
|
insulin resistance
|
J:151012
|
Esr1tm1Ksk/Esr1tm1Ksk
(B6.129P2-Esr1tm1Ksk)
|
impaired glucose tolerance
|
J:65806
|
insulin resistance
|
J:65806
|
Esr1tm1Ksk/Esr1tm1Ksk Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
insulin resistance
|
J:66077
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd)
|
decreased circulating glucose level
|
J:151012
|
decreased insulin secretion
|
J:151012
|
increased circulating glucose level
|
J:151012
|
increased insulin sensitivity
|
J:151012
|
Evi5tm1a(KOMP)Wtsi/Evi5tm1a(KOMP)Wtsi
(C57BL/6N-Evi5tm1a(KOMP)Wtsi/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
Evltm1b(KOMP)Wtsi/Evltm1b(KOMP)Wtsi
(C57BL/6N-Evltm1b(KOMP)Wtsi/H)
|
increased fasting circulating glucose level
|
J:211773
|
Exoc3tm2b(EUCOMM)Hmgu/Exoc3+
(C57BL/6N-Exoc3tm2b(EUCOMM)Hmgu/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
Exoc3l2em1(IMPC)J/Exoc3l2+
(C57BL/6N-Exoc3l2em1(IMPC)J/J)
|
impaired glucose tolerance
|
J:211773
|
Exosc3tm1.1(KOMP)Vlcg/Exosc3+
(C57BL/6N-Exosc3tm1.1(KOMP)Vlcg/Ucd)
|
increased fasting circulating glucose level
|
J:211773
|
Extl3tm1.1Okam/Extl3tm1Okam Tg(Ins2-cre)#Okam/0
(involves: 129P2/OlaHsd * ICR)
|
decreased circulating insulin level
|
J:148348
|
decreased insulin secretion
|
J:148348
|
impaired glucose tolerance
|
J:148348
|
Ezh1tm1b(EUCOMM)Wtsi/Ezh1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ezh1tm1b(EUCOMM)Wtsi/Nju)
|
increased circulating glucose level
|
J:211773
|
F2rl1tm1Cgh/F2rl1tm1Cgh
(involves: 129S4/SvJae * C57BL/6)
|
abnormal glucose homeostasis
|
J:130781
|
improved glucose tolerance
|
J:130781
|
Fabp1tm1Bin/Fabp1tm1Bin
(involves: 129/Ola * C57BL/6)
|
abnormal glucose homeostasis
|
J:83875
|
Fabp1tm1Ddsn/Fabp1tm1Ddsn
(involves: 129X1/SvJ * C57BL/6)
|
abnormal glucose homeostasis
|
J:87278
|
decreased circulating insulin level
|
J:87278
|
Fabp2tm1Mto/Fabp2tm1Mto
(B6.129S1-Fabp2tm1Mto)
|
increased circulating insulin level
|
J:64975
|
Fabp3Gt(XE705)Byg/Fabp3Gt(XE705)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal glucose homeostasis
|
J:167535
|
decreased circulating glucose level
|
J:167535
|
decreased liver glycogen level
|
J:167535
|
Fabp3tm1Bin/Fabp3tm1Bin
(involves: 129P2/OlaHsd * BALB/c)
|
hypoglycemia
|
J:54614
|
Fabp3tm1Jshr/Fabp3+
(B6.129-Fabp3tm1Jshr)
|
decreased circulating glucose level
|
J:102858
|
increased insulin sensitivity
|
J:102858
|
Fabp4tm1Brsp/Fabp4tm1Brsp
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal glucose homeostasis
|
J:37027
|
decreased circulating insulin level
|
J:57864
|
hypoglycemia
|
J:37027
|
insulin resistance
|
J:37027
|
Fabp4tm1Brsp/Fabp4tm1Brsp Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota)
|
decreased circulating glucose level
|
J:111878
|
increased insulin sensitivity
|
J:111878
|
Fabp4tm1Brsp/Fabp4tm1Brsp Fabp5tm1Hota/Fabp5tm1Hota
(involves: 129S7/SvEvBrd * C57BL/6J * SJL)
|
decreased circulating glucose level
|
J:217245
|
decreased glycogen level
|
J:217245
|
decreased skeletal muscle glycogen level
|
J:217245
|
Fabp4tm1Brsp/Fabp4tm1Brsp Fabp5tm1Hota/Fabp5tm1Hota Lepob/Lepob
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Lepob)
|
abnormal gluconeogenesis
|
J:111878
|
abnormal glucose homeostasis
|
J:111878
|
abnormal glycogen homeostasis
|
J:111878
|
decreased circulating glucose level
|
J:111878
|
decreased circulating insulin level
|
J:111878
|
improved glucose tolerance
|
J:111878
|
increased insulin sensitivity
|
J:111878
|
Fabp4tm1Brsp/Fabp4tm1Brsp Lepob/Lepob
(B6.Cg-Fabp4tm1Brsp Lepob)
|
improved glucose tolerance
|
J:111878
|
increased insulin sensitivity
|
J:111878
|
Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp5tm1Hota)
|
decreased circulating glucose level
|
J:81609
|
improved glucose tolerance
|
J:81609
|
increased insulin sensitivity
|
J:81609
|
Fabp5tm1Hota/Fabp5tm1Hota Lepob/Lepob
(involves: 129 * C57BL/6J * C57BL/10J * SJL)
|
decreased circulating glucose level
|
J:81609
|
improved glucose tolerance
|
J:81609
|
increased circulating insulin level
|
J:81609
|
increased insulin sensitivity
|
J:81609
|
Fabp5tm1Hota/Fabp5tm1Hota Lepob/Lepob
(B6.Cg-Fabp5tm1Hota Lepob)
|
improved glucose tolerance
|
J:111878
|
increased insulin sensitivity
|
J:111878
|
Fads1tm1.1(KOMP)Vlcg/Fads1tm1.1(KOMP)Vlcg
(C57BL/6N-Fads1tm1.1(KOMP)Vlcg/Ucd)
|
improved glucose tolerance
|
J:211773
|
Fahtm1Mgo/Fahtm1Mgo
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J))
|
hypoglycemia
|
J:16046
|
Fam3btm1Bkht/Fam3btm1Bkht
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal glucose homeostasis
|
J:167823
|
abnormal insulin clearance
|
J:167823
|
decreased insulin secretion
|
J:167823
|
impaired glucose tolerance
|
J:167823
|
increased circulating insulin level
|
J:167823
|
Fam13atm1e(KOMP)Wtsi/Fam13atm1e(KOMP)Wtsi
(C57BL/6N-Fam13atm1e(KOMP)Wtsi)
|
impaired glucose tolerance
|
J:258290
|
insulin resistance
|
J:258290
|
Fam83dem1(IMPC)Ccpcz/Fam83dem1(IMPC)Ccpcz
(C57BL/6N-Fam83dem1(IMPC)Ccpcz/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Fam126aem1(IMPC)Ccpcz/Fam126aem1(IMPC)Ccpcz
(C57BL/6N-Fam126aem1(IMPC)Ccpcz/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Fam163atm2b(KOMP)Wtsi/Fam163atm2b(KOMP)Wtsi
(C57BL/6N-Fam163atm2b(KOMP)Wtsi/Wtsi)
|
improved glucose tolerance
|
J:211773
|
Fam184btm2b(EUCOMM)Wtsi/Fam184btm2b(EUCOMM)Wtsi
(C57BL/6N-Fam184btm2b(EUCOMM)Wtsi/Tcp)
|
increased circulating glucose level
|
J:211773
|
Fam186btm1b(KOMP)Mbp/Fam186btm1b(KOMP)Mbp
(C57BL/6N-Fam186btm1b(KOMP)Mbp/J)
|
increased fasting circulating glucose level
|
J:211773
|
Fam221aem1(IMPC)Ccpcz/Fam221aem1(IMPC)Ccpcz
(C57BL/6N-Fam221aem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating glucose level
|
J:211773
|
Far2tm2b(KOMP)Wtsi/Far2tm2b(KOMP)Wtsi
(C57BL/6N-Far2tm2b(KOMP)Wtsi/J)
|
increased fasting circulating glucose level
|
J:211773
|
Farp1tm1b(EUCOMM)Hmgu/Farp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Farp1tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Farsatm2a(EUCOMM)Wtsi/Farsa+
(C57BL/6N-Farsatm2a(EUCOMM)Wtsi/Wtsi)
|
impaired glucose tolerance
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Fasntm1Sem/Fasntm1Sem Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
decreased circulating glucose level
|
J:127793
|
decreased circulating insulin level
|
J:127793
|
increased circulating glucagon level
|
J:127793
|
Fasntm1Sem/Fasntm1Sem Tg(Ins2-cre)25Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
increased circulating glucose level
|
J:127482
|
increased circulating insulin level
|
J:127482
|
Fastktm1.1(KOMP)Vlcg/Fastktm1.1(KOMP)Vlcg
(C57BL/6N-Fastktm1.1(KOMP)Vlcg/Ucd)
|
improved glucose tolerance
|
J:211773
|
Fbf1tm1a(EUCOMM)Wtsi/Fbf1tm1a(EUCOMM)Wtsi
(C57BL/6N-Fbf1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Fbgl1KK/Ta/Fbgl1KK/Ta
(involves: BALB/c * KK/Ta)
|
hyperglycemia
|
J:88209
|
Fbgl2KK/Ta/Fbgl2KK/Ta
(involves: BALB/c * KK/Ta)
|
hyperglycemia
|
J:88209
|
Fbp1m1Btlr/Fbp1m1Btlr
(C57BL/6J-Fbp1m1Btlr)
|
hypoglycemia
|
J:267693
|
Fbxl19tm1b(EUCOMM)Wtsi/Fbxl19+
(C57BL/6N-Fbxl19tm1b(EUCOMM)Wtsi/Nju)
|
decreased circulating glucose level
|
J:211773
|
Fbxo2tm1b(EUCOMM)Wtsi/Fbxo2tm1b(EUCOMM)Wtsi
(C57BL/6N-Fbxo2tm1b(EUCOMM)Wtsi/Nju)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Fbxo10tm1b(KOMP)Wtsi/Fbxo10tm1b(KOMP)Wtsi
(C57BL/6N-Fbxo10tm1b(KOMP)Wtsi/Nju)
|
decreased circulating glucose level
|
J:211773
|
Fbxo30tm1b(KOMP)Wtsi/Fbxo30+
(C57BL/6N-Fbxo30tm1b(KOMP)Wtsi/J)
|
improved glucose tolerance
|
J:211773
|
Fcortm1Jnak/Fcortm1Jnak
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
impaired glucose tolerance
|
J:184684
|
insulin resistance
|
J:184684
|
Fem1btm1Jfma/Fem1btm1Jfma
(involves: 129X1/SvJ * C57BL/6)
|
decreased insulin secretion
|
J:100017
|
impaired glucose tolerance
|
J:100017
|
Ffar1tm1Dgen/Ffar1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating insulin level
|
J:141957
|
decreased circulating glucagon level
|
J:141957
|
Ffar1tm1Heed/Ffar1tm1Heed
(Not Specified)
|
abnormal gluconeogenesis
|
J:129843
|
decreased circulating insulin level
|
J:129843
|
decreased insulin secretion
|
J:129843
|
improved glucose tolerance
|
J:129843
|
increased insulin sensitivity
|
J:129843
|
Ffar1tm1Lex/Ffar1tm1Lex
(involves: 129 * C57BL/6)
|
decreased insulin secretion
|
J:122092
|
Ffar1tm1Lex/Ffar1tm1Lex
(involves: C57BL/6 * C57BL/6J)
|
abnormal glucagon secretion
|
J:200805
|
increased circulating glucose level
|
J:200805
|
Ffar2tm1Fmgb/Ffar2tm1Fmgb
(involves: 129S/SvEv)
|
decreased circulating insulin level
|
J:191508
|
impaired glucose tolerance
|
J:191508
|
Ffar2tm1Soff/Ffar2tm1Soff
(B6.129-Ffar2tm1Soff)
|
increased circulating insulin level
|
J:227939
|
Ffar2tm2Soff/Ffar2tm2Soff Ffar3tm2.1Soff/Ffar3tm2.1Soff Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
abnormal insulin secretion
|
J:227939
|
improved glucose tolerance
|
J:227939
|
increased circulating insulin level
|
J:227939
|
Ffar3tm1Fmgb/Ffar3tm1Fmgb
(involves: 129S/SvEv)
|
impaired glucose tolerance
|
J:191508
|
Ffar3tm1Soff/Ffar3tm1Soff
(B6.129-Ffar3tm1Soff)
|
increased circulating insulin level
|
J:227939
|
Ffar4tm1.1Mbj/Ffar4tm1.1Mbj
(involves: C57BL/6)
|
abnormal insulin secretion
|
J:211675
|
Ffar4tm1Gdds/Ffar4tm1Gdds
(involves: 129 * C57BL/6)
|
impaired glucose tolerance
|
J:182599
|
increased circulating glucose level
|
J:182599
|
increased circulating insulin level
|
J:182599
|
insulin resistance
|
J:182599
|
Fgbtm1.1(KOMP)Vlcg/Fgbtm1.1(KOMP)Vlcg
(C57BL/6N-Fgbtm1.1(KOMP)Vlcg/Ucd)
|
impaired glucose tolerance
|
J:211773
|
Fgf21tm1.1Djm/Fgf21tm1.1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal gluconeogenesis
|
J:150831
|
decreased circulating glucose level
|
J:150831
|
hypoglycemia
|
J:150831
|
Fgf21tm1Emf/Fgf21tm1Emf
(B6.Cg-Fgf21tm1Emf)
|
abnormal glucose homeostasis
|
J:157309
|
impaired glucose tolerance
|
J:157309
|
increased circulating glucose level
|
J:157309
|
increased circulating insulin level
|
J:157309
|
increased liver glycogen level
|
J:157309
|
Fgf23tm1Blan/Fgf23tm1Blan
(involves: 129/Sv * C57BL/6)
|
decreased circulating insulin level
|
J:121006
|
hypoglycemia
|
J:121006
|
improved glucose tolerance
|
J:121006
|
Fgf23tm1Tyam/Fgf23tm1Tyam
(involves: C57BL/6 * CBA)
|
hypoglycemia
|
J:88172
|
Fgfr2tm2.3Dsn/Fgfr2+
(involves: 129 * C57BL/6 * FVB/N)
|
hypoglycemia
|
J:72517
|
Fgl1tm1Cuko/Fgl1tm1Cuko
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
|
abnormal gluconeogenesis
|
J:199844
|
hyperglycemia
|
J:199844
|
impaired glucose tolerance
|
J:199844
|
Fglu2KK/?
(involves: C57BL/6J * KK-Ay)
|
hyperglycemia
|
J:81517
|
FgluKK/TaJcl/FgluKK/TaJcl
(involves: C57BL/6Jcl * KK.B6-Ay/Jcl)
|
hyperglycemia
|
J:51880
|
Fitm2tm1.1Dls/Fitm2tm1.1Dls Tg(Fabp4-cre)1Rev/?
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal glucose homeostasis
|
J:212437
|
increased circulating insulin level
|
J:212437
|
insulin resistance
|
J:212437
|
Fkbp1btm1.1Okam/Fkbp1btm1.1Okam
(ICR.129-Fkbp1btm1.1Okam)
|
decreased insulin secretion
|
J:136192
|
impaired glucose tolerance
|
J:136192
|
Fmo5tm1Eshe/Fmo5tm1Eshe
(B6.129P2-Fmo5tm1Eshe)
|
abnormal glucose homeostasis
|
J:223365
|
decreased circulating glucose level
|
J:223365
|
decreased fasting circulating glucose level
|
J:223365
|
Fndc4tm1.1(KOMP)Vlcg/Fndc4tm1.1(KOMP)Vlcg
(C57BL/6N-Fndc4tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Fnip1LPAB.1/Fnip1LPAB.1
(C57BL/6J-Fnip1LPAB.1)
|
increased liver glycogen level
|
J:187318
|
Fnip1m1Btlr/Fnip1m1Btlr
(C57BL/6J-Fnip1m1Btlr)
|
increased cardiac muscle glycogen level
|
J:234285
|
Focadem1(IMPC)Bay/Focad+
(C57BL/6N-Focadem1(IMPC)Bay/BayMmucd)
|
improved glucose tolerance
|
J:211773
|
Fosl2tm2Wag/Fosl2tm2Wag Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
decreased circulating glucose level
|
J:211215
|
impaired glucose tolerance
|
J:211215
|
insulin resistance
|
J:211215
|
Foxa1tm1Gsc/Foxa1tm1Gsc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating insulin level
|
J:53312
|
decreased circulating glucagon level
|
J:53312
|
hypoglycemia
|
J:53312
|
Foxa1tm1Khk/Foxa1tm1Khk Foxa2tm1Khk/Foxa2tm1Khk Tg(Pdx1-cre)6Cvw/0
(involves: 129 * C57BL/6 * CBA * SJL)
|
hyperglycemia
|
J:143476
|
Foxa1tm1Stf/Foxa1tm1Stf
(Not Specified)
|
abnormal glucose homeostasis
|
J:57493
|
decreased circulating glucagon level
|
J:57493
|
decreased circulating insulin level
|
J:57493
|
decreased insulin secretion
|
J:57493
|
hypoglycemia
|
J:57493
|
impaired glucose tolerance
|
J:57493
|
Foxa2tm1.1Stf/Foxa2tm1.1Stf Tg(Nes-cre)1Kln/0
(B6.Cg-Foxa2tm1.1Stf Tg(Nes-cre)1Kln)
|
decreased circulating glucose level
|
J:155391
|
decreased circulating insulin level
|
J:155391
|
improved glucose tolerance
|
J:155391
|
increased insulin sensitivity
|
J:155391
|
Foxa2tm1Dnl/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal glucose homeostasis
|
J:95662
|
Foxa2tm1Khk/Foxa2tm1Khk
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA)
|
abnormal insulin secretion
|
J:70409
|
decreased circulating glucagon level
|
J:70409
|
hypoglycemia
|
J:70409
|
increased circulating insulin level
|
J:70409
|
increased glycogen level
|
J:70409
|
Foxa2tm1Khk/Foxa2tm1Khk Tg(Foxa3-cre)1Khk/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA)
|
decreased circulating glucagon level
|
J:96332
|
hypoglycemia
|
J:96332
|
Foxa3tm1Khk/Foxa3tm1Khk
(B6.129P2-Foxa3tm1Khk)
|
decreased fasting circulating glucose level
|
J:72595
|
decreased hepatic glucose production
|
J:72595
|
increased insulin sensitivity
|
J:216477
|
Foxi2tm1.1(KOMP)Vlcg/Foxi2tm1.1(KOMP)Vlcg
(C57BL/6N-Foxi2tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Foxm1tm1Rhc/Foxm1tm1Rhc Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal glucose homeostasis
|
J:111026
|
abnormal insulin secretion
|
J:111026
|
impaired glucose tolerance
|
J:111026
|
Foxo1tm1Rdp/Foxo1tm1Rdp Foxo3tm1Rdp/Foxo3tm1Rdp Foxo4tm1Rdp/Foxo4tm1Rdp Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA/J)
|
abnormal glucose homeostasis
|
J:215526
|
decreased circulating insulin level
|
J:215526
|
decreased insulin secretion
|
J:215526
|
hyperglycemia
|
J:215526
|
impaired glucose tolerance
|
J:215526
|
Foxo1tm1Rdp/Foxo1tm1Rdp Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA * FVB)
|
improved glucose tolerance
|
J:137845
|
Foxo1tm1Whb/Foxo1+
(Not Specified)
|
decreased liver glycogen level
|
J:79560
|
Foxo1tm1Whb/Foxo1+ Insrtm1Dac/Insrtm1Dac
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating glucose level
|
J:79560
|
Foxo1tm1Whb/Foxo1+ Pdpk1tm1Maka/Pdpk1tm1Maka Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
decreased circulating glucose level
|
J:109010
|
increased circulating insulin level
|
J:109010
|
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(Not Specified)
|
abnormal gluconeogenesis
|
J:179687
|
abnormal glucose homeostasis
|
J:179687
|
increased circulating glucose level
|
J:179687
|
increased circulating insulin level
|
J:179687
|
insulin resistance
|
J:179687
|
Foxo1tm2.1Dac/Foxo1tm2.1Dac Insrtm1Dac/Insr+
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating insulin level
|
J:179687
|
insulin resistance
|
J:179687
|
Foxo1tm2.1Dac/Foxo1tm2.1Dac Leprdb/Leprdb
(B6.Cg-Foxo1tm2.1Dac Leprdb)
|
impaired glucose tolerance
|
J:179687
|
increased circulating insulin level
|
J:179687
|
Foxo3tm1.1(KOMP)Vlcg/Foxo3tm1.1(KOMP)Vlcg
(C57BL/6N-Foxo3tm1.1(KOMP)Vlcg/J)
|
impaired glucose tolerance
|
J:211773
|
Foxo3tm1.1Rdp/Foxo3tm1.1Rdp
(involves: 129S6/SvEvTac * FVB/N)
|
impaired glucose tolerance
|
J:118179,
J:84269
|
Foxo6tm1(KOMP)Vlcg/Foxo6tm1(KOMP)Vlcg
(B6J.B6NTac-Foxo6tm1(KOMP)Vlcg)
|
abnormal gluconeogenesis
|
J:236585
|
decreased circulating glucose level
|
J:236585
|
decreased circulating insulin level
|
J:236585
|
decreased fasting circulating glucose level
|
J:236585
|
improved glucose tolerance
|
J:236585
|
increased insulin sensitivity
|
J:236585
|
FpliC57BL/6J/?
(involves: C57BL/6J * KK-Ay)
|
increased circulating insulin level
|
J:81517
|
Fshrtm1(KOMP)Vlcg/Fshrtm1(KOMP)Vlcg
(C57BL/6N-Fshrtm1(KOMP)Vlcg/Nju)
|
increased fasting circulating glucose level
|
J:211773
|
Fstl1tm1.1Ning/Fstl1tm1.1Ning
(involves: 129S4/SvJae * C57BL/6J * FVB/N)
|
increased glycogen level
|
J:171347
|
Fstl1tm1b(EUCOMM)Hmgu/Fstl1tm1b(EUCOMM)Hmgu
(C57BL/6N-Fstl1tm1b(EUCOMM)Hmgu/H)
|
impaired glucose tolerance
|
J:211773
|
Fstl3tm1Alsc/Fstl3tm1Alsc
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
decreased liver glycogen level
|
J:119526
|
improved glucose tolerance
|
J:119526
|
increased circulating insulin level
|
J:119526
|
increased insulin sensitivity
|
J:119526
|
FtoI367F/FtoI367F
(involves: C3H/HeH * C57BL/6J)
|
decreased circulating insulin level
|
J:152163
|
increased circulating glucagon level
|
J:152163
|
increased circulating glucose level
|
J:152163
|
Ftotm1.2Rdc/Ftotm1.2Rdc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL)
|
improved glucose tolerance
|
J:194922
|
Ftotm1Urt/Ftotm1Urt Lepob/Lepob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
insulin resistance
|
J:219118
|
Fzd3tm1b(EUCOMM)Hmgu/Fzd3+
(C57BL/6N-Fzd3tm1b(EUCOMM)Hmgu/H)
|
impaired glucose tolerance
|
J:211773
|
G0s2tm1(KOMP)Vlcg/G0s2tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased circulating insulin level
|
J:209000
|
improved glucose tolerance
|
J:209000
|
increased insulin sensitivity
|
J:209000
|
G0s2tm1Jgte/G0s2tm1Jgte
(involves: 129S7/SvEvBrd)
|
improved glucose tolerance
|
J:219653
|
increased insulin sensitivity
|
J:219653
|
G6pc2tm1Lex/G6pc2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating glucose level
|
J:141593
|
G6pc3tm1Rmob/G6pc3tm1Rmob
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating glucagon level
|
J:117664
|
G6pctm1.1Ics/G6pctm1.1Ics Albtm1(cre/ERT2)Mtz/Alb+
(involves: 129S2/SvPas * C57BL/6J)
|
increased liver glycogen level
|
J:195257
|
G6pctm1.1Ics/G6pctm1.1Ics Tg(Kap-icre)29066/2Sig/0
(involves: 129S2/SvPas * C57BL/6J * SJL)
|
increased kidney glycogen level
|
J:238264
|
G6pctm1Jyc/G6pctm1Jyc
(involves: 129S4/SvJae)
|
abnormal glucose homeostasis
|
J:33212
|
decreased circulating glucose level
|
J:33212
|
increased kidney glycogen level
|
J:33212
|
increased liver glycogen level
|
J:33212
|
G6pctm2.2Jyc/G6pctm2.2Jyc
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N)
|
hypoglycemia
|
J:155990
|
increased kidney glycogen level
|
J:155990
|
increased liver glycogen level
|
J:155990
|
Gaatm1.1Rabn/Gaatm1.1Rabn
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
increased brain glycogen level
|
J:76435
|
increased cardiac muscle glycogen level
|
J:76435,
J:48839
|
increased skeletal muscle glycogen level
|
J:76435,
J:48839
|
Gaatm1Rabn/Gaatm1Rabn
(involves: 129X1/SvJ * C57BL/6)
|
increased brain glycogen level
|
J:76435
|
increased cardiac muscle glycogen level
|
J:235790,
J:76435,
J:48839
|
increased liver glycogen level
|
J:235790
|
increased skeletal muscle glycogen level
|
J:235790,
J:48839,
J:73924
|
Gaatm1Rabn/Gaatm1Rabn Stbd1tm1Bsn/Stbd1tm1Bsn
(involves: 129X1/SvJ * C57BL/6)
|
increased cardiac muscle glycogen level
|
J:235790
|
increased liver glycogen level
|
J:235790
|
increased skeletal muscle glycogen level
|
J:235790
|
Gaatm1Rabn/Gaatm1Rabn Tg(CMV-GAA*P545L)#Kjv/0
(involves: 129X1/SvJ * C57BL/6)
|
increased glycogen level
|
J:219022
|
increased skeletal muscle glycogen level
|
J:219022
|
Gaatm1Vdp/Gaatm1Vdp
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB))
|
abnormal glycogen homeostasis
|
J:45386
|
Gaatm2Rabn/Gaatm2Rabn
(involves: 129X1/SvJ * C57BL/6)
|
increased brain glycogen level
|
J:76435
|
increased cardiac muscle glycogen level
|
J:76435
|
increased skeletal muscle glycogen level
|
J:76435
|
Gab1tm1Gsf/Gab1tm1Gsf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal glucose homeostasis
|
J:98318
|
decreased circulating glucose level
|
J:98318
|
decreased circulating insulin level
|
J:98318
|
decreased glycogen level
|
J:98318
|
improved glucose tolerance
|
J:98318
|
increased insulin sensitivity
|
J:98318
|
Gad2tm1b(EUCOMM)Wtsi/Gad2tm1b(EUCOMM)Wtsi
(C57BL/6N-Gad2tm1b(EUCOMM)Wtsi/Ieg)
|
impaired glucose tolerance
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Gad2tm1Miya/Gad2tm1Miya
(NOD.129P2-Gad2tm1Miya)
|
increased circulating glucose level
|
J:88785
|
Gadd45gip1tm2Kong/Gadd45gip1tm2Kong Tg(Ins2-cre)25Mgn/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
decreased insulin secretion
|
J:220742
|
impaired glucose tolerance
|
J:220742
|
Gaktm2Legr/Gaktm2Legr Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
decreased liver glycogen level
|
J:180119
|
Galtm1Wyn/Galtm1Wyn
(129P2-Galtm1Wyn)
|
abnormal circulating insulin level
|
J:105628
|
decreased insulin secretion
|
J:105628
|
Gasttm1(INS)Ez/Gast+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal insulin secretion
|
J:99270
|
improved glucose tolerance
|
J:99270
|
increased circulating insulin level
|
J:99270
|
Gasttm1(INS)Ez/Gast+ Ins2Akita/Ins2+
(involves: 129S4/SvJae * C57BL/6NSlc)
|
abnormal circulating glucose level
|
J:99270
|
Gatmtm1.1Isb/Gatmtm1.1Isb
(B6.129-Gatmtm1.1Isb)
|
abnormal gluconeogenesis
|
J:191142
|
abnormal glucose homeostasis
|
J:191142
|
decreased circulating glucose level
|
J:191142
|
decreased circulating insulin level
|
J:191142
|
improved glucose tolerance
|
J:191142
|
GaucKK/?
(involves: C57BL/6J * KK-Ay)
|
impaired glucose tolerance
|
J:81517
|
Gbe1m1Yty/Gbe1m1Yty
(C3HeB/FeJ-Gbe1m1Yty)
|
decreased cardiac muscle glycogen level
|
J:167233
|
Gbe1tm1.1Hoa/Gbe1tm1.1Hoa
(involves: 129S7/SvEvBrd)
|
abnormal glucose homeostasis
|
J:176889
|
decreased liver glycogen level
|
J:176889
|
decreased skeletal muscle glycogen level
|
J:176889
|
Gbe1tm1Hoa/Gbe1tm1Hoa
(involves: 129S7/SvEvBrd)
|
abnormal glucose tolerance
|
J:176889
|
decreased circulating glucose level
|
J:176889
|
decreased glycogen catabolism rate
|
J:176889
|
increased liver glycogen level
|
J:176889
|
increased skeletal muscle glycogen level
|
J:176889
|
Gbe1tm2.1Hoa/Gbe1tm2.1Hoa
(involves: 129S7/SvEvBrd)
|
abnormal glucose homeostasis
|
J:226481
|
abnormal muscle glycogen level
|
J:226481
|
decreased fasting circulating glucose level
|
J:226481
|
increased brain glycogen level
|
J:226481
|
increased glycogen level
|
J:226481
|
increased liver glycogen level
|
J:226481
|
Gbe1tm2Hoa/Gbe1tm2Hoa
(involves: 129S7/SvEvBrd)
|
abnormal muscle glycogen level
|
J:226481
|
increased brain glycogen level
|
J:226481
|
increased glycogen level
|
J:226481
|
increased liver glycogen level
|
J:226481
|
Gbp2tm1b(KOMP)Wtsi/Gbp2tm1b(KOMP)Wtsi
(C57BL/6N-Gbp2tm1b(KOMP)Wtsi/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Gctm1.1(KOMP)Vlcg/Gctm1.1(KOMP)Vlcg
(C57BL/6N-Gctm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating glucose level
|
J:211773
|
Gcgtm1Yhys/Gcgtm1Yhys
(B6.129S6-Gcgtm1Yhys)
|
decreased circulating insulin level
|
J:154694
|
improved glucose tolerance
|
J:154694
|
increased circulating glucose level
|
J:154694
|
increased insulin sensitivity
|
J:154694
|
Gcgrem1Tshu/Gcgrem1Tshu
(involves: C57BL/6J)
|
decreased fasting circulating glucose level
|
J:279017
|
Gcgrem2Smoc/Gcgrem2Smoc
(C57BL/6J-Gcgrem2Smoc)
|
decreased fasting circulating glucose level
|
J:300368
|
improved glucose tolerance
|
J:300368
|
increased circulating glucagon level
|
J:300368
|
Gcgrtm1Jcp/Gcgrtm1Jcp
(DBA/1LacJ-Gcgrtm1Jcp)
|
decreased circulating glucose level
|
J:176507
|
decreased circulating insulin level
|
J:176507
|
increased circulating glucagon level
|
J:176507,
J:73926
|
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129/Sv * C57BL/6J * SJL)
|
decreased circulating glucose level
|
J:81772
|
decreased circulating insulin level
|
J:251829
|
hypoglycemia
|
J:251829,
J:81772
|
improved glucose tolerance
|
J:81772
|
increased circulating glucagon level
|
J:251829,
J:81772
|
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129 * C57BL/6J * SJL)
|
decreased circulating insulin level
|
J:208604
|
improved glucose tolerance
|
J:208604
|
increased circulating glucagon level
|
J:208604
|
increased glucagon secretion
|
J:208604
|
increased insulin sensitivity
|
J:208604
|
Gcgrtm1Mjch/Gcgrtm1Mjch Slc38a5tm1(KOMP)Vlcg/Slc38a5tm1(KOMP)Vlcg
(involves: 129/Sv * C57BL/6 * C57BL/6J * C57BL/6NTac * SJL)
|
decreased circulating insulin level
|
J:251829
|
hypoglycemia
|
J:251829
|
increased circulating glucagon level
|
J:251829
|
Gcgrtm2.1Mjch/Gcgrtm2.1Mjch Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA * SJL)
|
abnormal glucose homeostasis
|
J:208604
|
decreased circulating glucose level
|
J:208604
|
decreased circulating insulin level
|
J:208604
|
hypoglycemia
|
J:208604
|
improved glucose tolerance
|
J:208604
|
increased circulating glucagon level
|
J:208604
|
increased insulin sensitivity
|
J:208604
|
Gckem1(IMPC)H/Gck+
(C57BL/6NTac-Gckem1(IMPC)H/H)
|
impaired glucose tolerance
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
GckGena348/Gck+
(involves: BALB/c * C3H/He)
|
hyperglycemia
|
J:82809,
J:79719,
J:90389
|
impaired glucose tolerance
|
J:90389
|
GckGena348/GckGena348
(involves: BALB/c * C3H/He)
|
hyperglycemia
|
J:90389
|
impaired glucose tolerance
|
J:90389
|
GckGls006/Gck+
(C3HeB/FeJ-GckGls006)
|
decreased circulating insulin level
|
J:189544
|
decreased insulin secretion
|
J:189544
|
hyperglycemia
|
J:189544
|
impaired glucose tolerance
|
J:189544
|
increased circulating glucose level
|
J:189544
|
GckGls006/GckGls006
(C3HeB/FeJ-GckGls006)
|
hyperglycemia
|
J:137483,
J:189544
|
increased circulating glucose level
|
J:189544
|
|